Life Science Report Vienna 2011

Coverentwürfe2 copy.indd 1 07.11.11 17:06Coverentwürfe2 copy.indd 2 02.11.11 14:38Coverentwürfe2 copy.indd 2 02.11.11 14:38

Vie

nna

Life

Sci

ence

Rep

ort

Sec

tor

Sur

vey:

Fac

ts a

nd D

irect

ory

2011

/201

2

ImprintThis report is based on data obtained through the evaluation of a written survey among Austria's life science companies carried out by BIOCOM AG, Berlin in close cooperation with austria wirt-schaftsservice and LISAvienna in spring 2011. For more information please refer to page 153. The editorial staff comprises Dr. Patrick Dieckhoff, Dr. Bernd Kaltwaßer (both BIOCOM) and DI (FH) Maria Hinnerth (LISAvienna). The data were collected by Simone Ding (BIOCOM). The layout was designed by Benjamin Röbig (BIOCOM) and CREVO. We thank all companies supporting this sur-vey! The layout, graphics and other contents of this brochure of the Viennese life science cluster are protected by copyright law.Berlin, November 8, 2011

Contact:LISAvienna, Ungargasse 37, A-1030 Vienna, www.LISAvienna.atBIOCOM AG, Lützowstrasse 33–36, D-10785 Berlin, www.biocom.de

3

Preface

By building on more than a century of experience in science and medi-cal research, Vienna has advanced to become one of the leading life science hubs in Europe in the past 20 years. This success is based on outstanding research performed by the scientists at the city’s universities and research in-stitutions, on the entrepreneurial spirit and innovations developed by dynamic life science start-ups and established companies as well as on the financial and strategic investments made by the City of Vienna and the federal govern-ment.

Over the last 10 years, the Austrian national funding bank, austria wirt-schaftsservice (aws), has awarded roughly 430 million euros in grants, loans and guarantees to life science companies. Since 1998, the ZIT – The Technology Agency of the City of Vi-enna, the Vienna Science and Tech-nology Fund and the Vienna Business Agency have also funded life science projects to the tune of 117 million eu-ros. The custom-tailored funding and service instruments of these and other funding agencies such as FFG and IN-iTS, leveraged a multitude of private in-

Peter Halwachs and Johannes SarxLISAvienna Executive Board

vestments and cooperation with large international enterprises. Moreover, a perfect interaction between universi-ties, research institutes, and industry resulted in a knowledge and technol-ogy transfer that has been crucial for successful company developments.

Since 2002, Life Science Austria Vi-enna (LISAvienna) has been success-fully operating as a life science cluster organization providing information and advice for potential start-ups and new arrivals, as well as for life science busi-nesses in general. The five core activi-ties of LISAvienna include consulting, marketing, qualification, networking, and the compilation of life science re-lated strategic studies.

With this report LISAvienna aims to depict Vienna as a leading European research and business location in the field of the life sciences. The report provides the latest facts and figures which underscore the significance of the life sciences in Vienna. And is the first statistical survey according to the internationally accepted OECD and GMDN standards in Austria. In 2010, the Life Science Cluster Vienna

counted more than 400 companies of which 99 were biotech and medtech companies that were producing or developing products and processes in these fields. These core enterprises employed more than 9,000 people and generated 1.7 billion euros in sales in 2010. Apart from these business ac-tivities, basic research is performed by 22 research institutions, which em-ploy over 14,000 people. The survey is complemented by success stories of outstanding companies and provides an insight into the first-rate academic landscape in Vienna. It also includes an extensive company directory to en-courage you to discover more about Vienna's scientific and business po-tential.

Finally, we invite you to join BIO-Eu-rope 2013 in Vienna, Europe’s largest partnering conference serving the glo-bal biotech industry.

We thank all those who contributed to this report and hope you enjoy read-ing it.

5

Content

intro

Preface 3

Life Sciences in Vienna at a Glance 6

Vienna – Life Science Hub at the Heart of Europe 8

Academia

Map: Academic Hot Spots in Vienna 14

Spotlight on Research and Teaching 16

Academic Directory 18

Industry

Map: Life Science Companies in Vienna 28

Biotechnology in Vienna – Facts & Figures 31

Biotech Success Stories 34

Medtech in Vienna – Facts & Figures 39

Medtech Success Stories 42

Company Directory 47

Glossary 151

Methodology 153

Imprint 155

6 ComPanies

Life sciences in Vienna at a GlanceCompanies

Vienna’s share in austrian Life sciences – Dedicated & active

Life Science Facts & FiguresVienna has a long tradition of excel-lent scientific and medical research. The traditions of the Second Vienna Medical School are manifested today in a focus on medical biotechnology centering on anti-infectives, immunol-ogy, oncology, production technologies and vaccinations. Another core area is medical technology, in particular elec-tromechanical medical devices and software for medicine, telemedicine and e-health.

CompaniesA recent study revealed that Vienna is currently home to more than 400 life science companies. Of these, 99 are considered to be active and dedicated biotechnology and medical technology companies, according to the OECD and GMDN criteria (see definition p. 151).

Fig. 1: Total number of life science companies, employees (headcount) and revenues in the Vien-nese life science scene (2010).

48%

Vienna

rest of austria

turnover

biotech

29% 71%

medtech

52%

Companies

biotech

58%

medtech

37% 63%

42%

biotech

employees

27%

55%

73%

45%

medtech

employees in biotech companies: 7,498

employees in medtech companies: 1,661

revenues in biotech companies: eUr 883 million

revenues in medtech companies: eUr 835 million

Biotech companies: 61

medtech companies: 38

Life science related com-panies: 305

Dedicated & active life science companies: 99

total number of life science companies:

404

Revenues in dedicated & active life science companies:

eUr 1,718 m

Employees in dedicated & active

life science companies:

9,159

Fig. 2: Total share of Vienna’s companies in Austria’s life science industry in terms of company number, employees and turnover (2010).

7aCaDemia

Universities: 5

applied universities: 2

non-profit research institutions: 10

other: 5

total number of publications:

5,182total number of life science students:

35,288

total number of employees in

research institutions:

14,102

academia

total number of life science research institutions:

22

The basis for successful in-house company research often originates in outstanding academic research. In life science research and education, Vien-na ranks top in Austria: Twenty-two re-search institutions are located in Vienna. Five universities, two applied universi-ties, ten non-profit research institutes and five other organizations perform noteworthy research and teaching ac-tivities in the life sciences. With more than 35,000 students in the life scienc-es alone, Vienna educates more young scientists than any other city in Austria. Altogether, the 22 research institutions employ over 14,000 people. Numerous publications (5,182 in 2010) in interna-tional journals are evidence of the ex-cellent research activities.

Fig. 3: Life science research in Vienna: number of institutions, employees (headcount), students and publications

These employ over 9,000 staff. The ac-tive and dedicated biotechnology and medical technology companies gener-ated revenue to the tune of 1.7 billion euros in the year 2010. As expected, the research & development (R&D) to sales ratio in dedicated biotech com-panies of 151% is substantially higher than the R&D to sales ratio of dedicat-ed medtech companies which is 26%.The difference is due to the intensive

research and the long development times that are necessary for biotech-nological products. Furthermore, the biotech companies are very young compared to the medtech companies. The medtech companies, with an aver-age age of 17.9 years, are more than twice as old as the average biotech company, which is 7.1 years. Vienna’s share in the Austrian life sciences is re-markable: 58% of all Austrian biotech-

nology companies are located in Vienna. They account for 29% of the total rev-enue and employ 55% of all staff work-ing in the Austrian biotech industry. Also, in the area of medical technology many companies are located in Vien-na: 37% of all Austrian firms are in the capital city. They generate 52% of the total revenue with 27% of the employ-ees working in the medical technology branch in Austria.

8 introDUCtion

Vienna – Life science Hub at the Heart of europe

Since the European Union has expand-ed eastwards, Vienna has reinforced its role as a business, academic and cultural hub for Central and Eastern Europe. With a highly qualified multina-tional workforce, a superb infrastruc-ture and public service, Vienna is an

ideal location for investments in the life sciences as well as for collaborations with researchers at first-rate academic institutions and hospitals.

Good Quality of Life

Vienna has always been known throughout the world as a city defined by its long history of art and culture. In addi-tion to its numerous cultural offerings, the city is full of inherent natural beau-ty. Vienna is consistently ranked at the top of the list in international surveys on the quality of life. According to the 2010 Mercer Quality of Living Survey, in which 221 cities were evaluated on the basis of personal safety, political and economic stability, healthcare, educational and recreational opportu-nities, Vienna was once again rated as the city with the world’s best quality of life.

At the Heart of Europe

Over the past 20 years, Vienna has grown into the political and economic center of Central Europe. The city is an ideal business location: whether as an east-west interface or as the headquar-ters for a company’s Central and East-ern European (CEE) business activities. Vienna is home to the CEE headquarters of some 300 international corporations such as Eli Lilly and Siemens. Vienna's international airport offers more non-stop flights to CEE destinations than any other airport. As a Danube port, a major rail hub and with its well-developed road systems and excellent public transport system Vienna’s infrastructure is ideal.

Welcoming Business Environment

Companies that settle in Vienna ap-preciate not only the proximity to the

Factbox Vienna

› Austria's capital city

› Area 415 km2

› Population 1.7 million (Metro area 2.4 million, Austria 8.4 million)

› Population growth 2000 – 2010 + 10 %

› GDP per capita 44,700 euros (Austria 34,000 euros)

XXXXX

We bring LifeSciences to Life.

www.awsg.at

50.000 Euro

Temporary Management:Financing of complementary management expertise awsg.at/maz

1.000.000 Euro

Seedfi nancing:Financing of the start-up phaseof high-tech companies seedfi nancing.at

200.000 Euro

PreSeed:Financing of the pre-start phase preseed.at

Wanted: Innovative products and procedures in the life sciences sector. What we offer: Optimal fi nancing mix for maximum growth effects. aws business development bank supports the establishment and development of high-tech companies with fi nancing and targeted consultation, thereby strengthening Austria as a business location. For details and conditions of fi nancing please visit www.awsg.at

austria wirtschaftsservice

10 introDUCtion

growth markets of the neighboring countries in Eastern Europe, but also the attractive tax system with a low corporate tax of 25% and the op tion of group taxation. Group taxation re-ductions allow international groups and companies with Austrian sub-sidiaries to transfer profits and losses between group subsidiaries and to re-duce the overall corporate tax liability to a minimum. In addition to low rates of tax, there are generous deductions and exemptions for investments in research and education. R&D allow-ances of up to 25% (in special cases up to 35%) are available on research and development expenditures. The Austrian tax system grants a tax pre-mium for research amounting to 10%. For the education and training of em-ployees employers can claim a tax al-lowance of 20%.

Dynamic Start-ups and

Global Players

The growing importance of Vienna as a life science cluster is reflected in the numerous start-ups, the emergence of new research centers and the es-tablishment of subsidiaries by leading global life science companies. Numer-ous international corporations have a notable presence in Vienna. In addi-tion to pursuing their sales activities in Central and Eastern Europe from their Vienna base, some of these subsidiar-ies also operate research and produc-tion facilities here.

In 1997, Austria became the Baxter Group‘s biggest location outside Amer-ica. Around 3,800 people are currently employed in production, research (bio-sciences) and marketing organizations in Vienna and the surrounding area. Their activities include the develop-ment and production of blood plasma

compounds, recombinant coagulation factors, fibrin sealants and vaccines such as the FSME vaccine, which pro-tects against tick-borne encephalitis. In 2008, Baxter also founded Baxter Innovation GmbH, in which all Austrian and international R&D is clustered.

The Boehringer Ingelheim Regional Center Vienna (RCV) is responsible for the pharmaceutical business in more than 30 Central and Eastern European countries and manages the entire clini-cal research of this region. The com-pany is also the dedicated oncology research center of the international group as well as an important site for biopharmaceutical development and production. With more than 1,100 em-ployees and research expenses of 143 million euros in 2010, the Boehringer Ingelheim RCV ranks among the top companies and employers of the Aus-trian life science sector.

The Austrian subsidy of Eli Lilly was founded in June 1976. Altogether al-most 190 employees work in the dif-ferent branches in Vienna. Since 1997, Vienna has been the company’s head-quarters for CEE (Central and Eastern Europe), for parts of the management of the EMS region (European Mid Size) and AMERASIA (Africa, Middle East, Russia and Asia), as well as the Re-gional Medical Center responsible for research activities. The site in Vienna is a central hub and a platform for inter-national research activities. The Area Medical Center Vienna is responsible for the planning, coordination and im-plementation of clinical studies.

Sanochemia Phamazeutika AG was founded in 1990 and has been listed on the Frankfurt Stock Exchange since 1995. Sanochemia is a research-based

1 Vienna Austria 108.6

2 Zurich Switzerland 108

3 Geneva Switzerland 107.9

4 Vancouver Canada 107.4

4 Auckland New Zealand 107.4

6 Dusseldorf Germany 107.2

7 Frankfurt Germany 107

7 Munich Germany 107

9 Bern Switzerland 106.5

10 Sydney Australia 106.3

Quality of Life – top 10

Quality of life according to the Mercer Quality of Living Survey 2010; 100 = New York; Source: Mercer 2010

Table 1

Von der Forschung zum ProduktInformationen zu

Förderprogrammen,

aktuellen Calls und

Beratungsangeboten:

www.zit.co.at

T +43 4000 86 165

Die ZIT unterstützt Wiener Unternehmen

als Technologieagentur der Stadt Wien im

gesamten Innovationsprozess: mit mone-

tären Förderungen, begleitenden Beratungs-

angeboten und technologiespezifischer

Infrastruktur. Informieren Sie sich,

welches Förderprogramm für Ihr Projekt am

besten passt und nutzen Sie die Möglichkeit

der unbürokratischen Technologieberatung,

um mit ExpertInnen aus dem ZIT-Netzwerk

zur Lösung technologischer Fragen in

Verbindung zu treten.

From Science To ProductsInformation on

funding programmes,

current calls and

consulting offers:

www.zit.co.at

T +43 4000 86 165

In its role as the technology agency of

the City of Vienna, ZIT provides support

to Vienna-based firms throughout the

entire innovation process: with monetary

grants, related consulting offers and a

technology-specific infrastructure.

Inform yourself which funding programmes

are best suited for your project. Take

advantage of unbureaucratic technology-

oriented consulting and establish contact

with experts from the ZIT network to solve

technological problems.

12 introDUCtion

pharmaceuticals organization special-izing in drug development for the treat-ment of diseases affecting the central nervous system. Sanochemia‘s best-known product is synthetically pro-duced galantamine which is used in the treatment of Alzheimer’s disease.

Otto Bock Healthcare Products GmbH develops and manufactures high-tech prosthetics and innovative products for people with limited mobility around the world. The Austrian subsidiary of the German Otto Bock Group is a compe-tence center for mechatronics. The leg prosthesis system C-Leg® controlled by a microprocessor and the myoelectric arm prosthesis DynamicArm®, which helps the patient regain elbow function, were both fully developed in Vienna.

These global players are supplement-ed by a fast growing number of bio-tech and medical technology start-ups and a superior research infrastructure.

The City of Vienna strongly promotes life sciences with financial incentives and the fostering of networks. These networks as well as state-of-the-art technology hubs facilitate interaction between global players, start-ups, re-search institutions and educational fa-cilities with the aim of ensuring the fast and effective transfer of technologies between the scientific and the busi-ness communities. Up to 2018, the City of Vienna together with the Republic of Austria will be investing 52 million eu-ros into the Campus Vienna Biocenter (CVBC) a cutting-edge shared core fa-cility. Over a 10-year period the city will invest another 10 million euros in the Vi-enna Institute of BioTechnology Equip-ment GmbH located at LifeScience Vienna Muthgasse in the 19th district. In addition to the state-of-the-art infra-structure, customized funding for start-ups and established companies is of-fered by different agencies.

Tailored Funding and Services

Austria and in particular Vienna of-fer a broad range of financial sup-

port programs from national and city agencies. On behalf of the Austrian Federal Ministry of Economy, Family and Youth, austria wirtschaftservice (aws), the Austrian funding bank aims to stimulate the economy through fi-nancial support and know-how trans-fer. aws provides financial support to high-technology start-ups with its programs “LISA PreSeed” and “LISA Seedfinancing”. The PreSeed pro-gram provides funding for proof of principle experiments or the develop-ment of prototypes before a high-tech business is founded. The maximum amount of this nonrefundable grant is 200,000 euros. Starting up an inno-vative and internationally competitive high-tech company requires consider-able know-how, a lot of courage and sufficient capital. With “LISA Seedfi-nancing” aws funds the start-up phase of young high-tech companies with up to EUR 1 million, combined with cus-tomized advice and support. These funding programs are embedded in a comprehensive life science program, ranging from the life science business plan competition “Best of Biotech” to

13introDUCtion

international location marketing under the national brand Life Science Austria (LISA). The business financing by aws is supplemented by the Austrian Sci-ence Fund (FWF) which funds basic academic research and the Austrian Research Promotion Agency (FFG) which is in charge of applied research funding.

In Vienna several agencies supple-ment federal funding: ZIT – The Tech-nology Agency of the City of Vienna, the Vienna Science and Technology Fund (WWTF), the Vienna Business Agency and the university business incubator INiTS.

ZIT provides support mainly for small and medium-sized enterprises loca-

ted in Vienna in the form of grants, technology-specific infrastructure, as well as free services like technology transfer consulting. ZIT’s research funding program supports indus-trial and experimental R&D projects managed by Viennese businesses, where the investment is expected to result directly or indirectly in product, service or process innovations. Cash grants of up to 500,000 euros are awarded for the best R&D projects.

In 2010, 168 life science projects in Vienna were able to attract fund-ing amounting to 35.5 million euros (funding cash value) from the differ-ent available funding programs of aws, FFG, Vienna Business Agency, WWTF and ZIT.

Lisavienna – Life science austria ViennaLISAvienna aims to unlock the potential of the life sciences in Vienna by supporting the commercial application of scientific discoveries. As a joint initiative of the Republic of Austria and the City of Vienna, LISAvienna helps to ensure that the eco-nomic potential of the life sciences is fully exploited and turned into marketable products, improved processes and new services. The main focus of LISAvienna’s activities is on custom-tailored advice and assistance for innovative enterprises. The initiative is supported by austria wirtschaftsservice (aws) and ZIT – The Technology Agency of the City of Vienna.

What We Offer LISAvienna provides a broad range of essential services free of charge to entrepreneurs, investors and researchers in Austria’s largest life science location:

› Consulting – Contacts and advice on financing and subsidies, infrastructure, technology competences and collaborations, human resources as well as internationalization › Marketing – Positioning Vienna as a significant research and business location at international trade fairs and providing information about the life sciences in Vienna in local and national media › Qualification – Life science related seminars on the market and regulatory environment, legal aspects as well as financing and organization for entrepreneurs, researchers and students › Networking – Setting up and strengthening networks in the life science community with the aim of fostering fruit-ful exchanges of ideas and experience › Knowledge – Preparation of analyses, background papers and studies on the strategic development and posi-tioning of Vienna as a life science location

Visit www.LISAvienna.at to learn more about Vienna as a top location for the life sciences and get further information on the support and funding available on site.

14 aCaDemia

academic Hot spots in Vienna

University of technology

the tU Vienna is among the most successful technical univer-sities in europe and is austria's largest technical research and educational institution. the tU Vienna provides expertise in bio-analytics and sensor development, biomechanics, biomedical engineering, chemical technologies, electrodynamics, material sciences and software development. an experienced technolo-gy transfer unit forms the professional interface towards indus-try partners to catalyze partnerships that bring new develop-ments to the market. www.tuwien.ac.at

Vienna is home to seven universities, ten non-profit research institutes and five other organizations per-

forming life science research. This makes the city a globally renowned hot spot for research and teach-

ing activities that attracts more than 35,000 students in life sciences alone. They are trained by a grow-

ing number of researchers and teaching staff that in 2010 amounted to more than 14,000 people – the

majority (52%) of them are female. With almost 5,200 life science papers in peer-reviewed journals, the

scientific output in life sciences was significant. 45 life science patents filed in 2010 prove that Vienna is

also a fertile ground for technology transfer.

Lifescience Vienna muthgasse

Lifescience Vienna muthgasse is the most recent life science lo-cation in Vienna. it bundles university and research institutions such as the University of Natural Resources and Life Sciences (BOKU) or the Austrian Institute of Technology (AIT) with life sci-ences companies and organizations offering beneficial synergies. With state-of-the-art infrastructure, Lifescience Vienna muthgas-se accommodates the requirements of different fields of research such as biology, chemistry and physics. the first phase of the spectacular project ”Biotech i” with more than 24,000 m² is alrea-dy in use. the next building, Biotech ii will provide 29,000 m² of office and lab space. the WHite sPaCe will add another 25,500 m² of rental space. www.lifescience-vienna.com

15aCaDemia

Campus Vienna Biocenter

the CVBC at neu marx, is one of the leading international bio-medical research centers worldwide. With a broad spectrum of research institutions it is home to a variety of research laborato-ries, several internationally successful biotech companies, recent start-ups as well as privately and publicly funded services. in ad-dition, teaching is a major activity on the campus. access to state-of-the-art infrastructure has become an important and decisive element for cutting-edge research. therefore, the CVBC set up the Campus science support Facilities (CsF GmbH) featuring a comprehensive range of new technologies with substantial fun-ding from the austrian ministry of science and research and the City of Vienna. www.viennabiocenter.org

medical University of Vienna

the Campus of the medUni Vienna is austria’s largest research and teaching institution. its activities are based on three key pillars – research, teaching and patient care. the heart of the campus is Vienna’s General Hospital (aKH), europe’s biggest hospital. each year 100,000 patients are treated as inpatients in 31 university clinics, 48,000 surgeries are conducted and 605,000 outpatients receive treatment in the day-clinics of the aKH. numerous medi-cal institutions, such as st. anna Children’s Hospital, and a variety of research institutes and business enterprises have established themselves in the vicinity. their presence offers innovative syn-ergies and incentives, all of which ultimately benefit the patients. www.meduniwien.ac.at

University of Veterinary medicine

the Vetmeduni Vienna is austria's only university for veterinary education and research. the facility centers around an animal hospital for clinically demanding cases. equipment and facilities for teaching and research are state-of-the-art and numerous associated organizations as well as life science companies are located on the campus. the objectives of Vienna's Vetmeduni focus on new goals in preventive and curative veterinary medi-cine for livestock, companion animals, and wildlife, and on safe food from healthy animals. VetWiDi GmbH, an enterprise of the Vetmeduni Vienna, forms the interface between research and economics at the university and supports the scientists in all

aspects of university technology transfer. www.vetmeduni.ac.at

16 aCaDemia

the Life sciences in Vienna: spotlight on research and teaching

A brochure on the life sciences in Vi-enna would be incomplete without considering research activities which go beyond the business side. In fact, commercial activities in the life sci-ences are often based on outstanding academic research. LISAvienna asked 22 institutions active in the life scienc-es to participate in a survey* to gather up-to-date statistics on life science research activities in Vienna. Because commercial activities in biotech and medtech are linked to many different disciplines such as agriculture, biol-ogy, chemistry, engineering, material sciences, medicine, pharmaceutics and veterinary medicine, a very broad and extended life science definition has been applied for the set-up of the sample. The bandwidth of the insti-tutes’ landscape is particularly large. It includes classical academic educa-tion at the University of Vienna as well as training in specialist disciplines in basic and applied research facili-ties. This extensive scientific range traditionally attracts a large number of national and international private companies that support research with large amounts of external funding or even completely self-financed institu-tions. Numerous innovations owe their existence to this proximity between research and industry. Short profiles of the 22 organizations that contrib-

uted their data are included in this re-port (see p. 18).

Key Figures at a Glance

Vienna is home to seven universities, ten non-profit research institutes and five other organizations performing noteworthy research and teaching activities in the life sciences. By the end of 2010, these institutions em-ployed roughly 14,100 people in the life sciences (n = 21), 52 % of them were women (n = 20). With more than 35,000 students in the life sciences alone, Vienna educates more young scientists than any other city in Aus-tria. 5,182 life science papers were published in peer-reviewed journals by researchers based in the organiza-tions included in the sample (n = 20). Furthermore, 45 (n = 18) life science patents were filed last year. In 2010, the total life science budget of the organizations amounted to 699 mil-lion euros (n = 16), of this amount 194 million euros (n = 19) came from third-party funding.

Long Traditions and Cutting-edge Research

Vienna owes its success as one of the most important life science centers in Europe today to its long tradition

in scientific and medical research. Names such as Semmelweis, Billroth and Landsteiner have all taken their place in the annals of the city’s history. The University of Vienna, founded in 1365, is Austria‘s largest univer-sity. The Medical University of Vi-enna was originally founded in 1365 as a Medical Faculty of the Univer-sity of Vienna. Since 2004 the Med-Uni Vienna is an autonomous uni-versity. The University of Veterinary Medicine was founded in 1765 by Empress Maria Theresa as the first veterinary medicine educational es-tablishment in the German-speaking world. In 1815, the Vienna University of Technology was established and in 1872 the University of Natural Re-sources and Life Sciences was found-ed. Since the 1990s the institutional landscape has diversified immensely. Nowadays cutting-edge research is not only performed in well-estab-lished universities but also in research institutions such as the Max F. Perutz Laboratories, the Institute of Mo-lecular Pathology (IMP) or institutes operated by the Austrian Academy of Sciences (ÖAW) like the Center of Molecular Medicine (CeMM), the Gregor Mendel Institute of Molecular

* Detailed information on the methodology can be found at www.LISAvienna.at

academic institutions – Facts & Figures iNumber of research institutions active in life science covered by the report .............................................................................. 22

Universities .......................................................................................................................................................................... 5

Applied universities ............................................................................................................................................................. 2

Non-profit research institutes.............................................................................................................................................10

Other .................................................................................................................................................................................... 5

Patent applications in the life sciences in 2010 (n = 18) ................................................................................................................ 45

Total life science budget in 2010 (n = 16) ...................................................................................................................EUR 698.44 M

Third-party funds spent on life science research in 2010 (n = 19) .............................................................................EUR 194.10 M

Table 2

17aCaDemia

Plant Biology (GMI) and the Institute of Molecular Biotechnology (IMBA).

New Types of Collaborations

New forms of institutions have emerged to address research ques-tions that concern tangible societal and industrial problems and to allow for new types of collaboration with commercial and societal partners. These include institutes and labs sup-ported by the Christian Doppler Re-search Association (CDG), the Lud-wig Boltzmann Gesellschaft (LBG) and the Karl Landsteiner Association. Furthermore, technology-focused competence centers like the Austrian Centre of Industrial Biotechnology (ACIB) and the Center for Virtual Real-ity and Visualization Research (VRVis) have been set up and complement existing institutions like the Austrian Institute of Technology (AIT) and the Austrian Research Institute for Chem-istry and Technology (OFI).

Talent is the Key to Success

Perfect organizational structures and a top infrastructure are without a doubt crucial for the delivery of excellent re-search results. However, the people working in these structures are the key to success. Their talent and motiva-

tion make the difference. At the end of 2010, 1,186 highly educated and motivated people worked in Vienna for the non-profit research institutions which were included in LISAvienna's survey. Women accounted for half this number. These employees are active in a wide variety of professions from medical doctors, clinical researchers, lab researchers, computer specialists and engineers to project managers, financial experts, administrative and public relations experts. Today, the life sciences also attract a large number of students: At Vienna‘s universities 35,288 students are registered in these courses, of these 33,184 at universities and 2,104 at applied universities.

Input and Output

Despite the controversial discussions on peer-review processes, they are still the standard of quality assur-ance in the academic world. Only publications that have been reviewed by experienced colleagues are pub-lished in high impact journals with an international readership. Researchers at the institutions that participated in LISAvienna's survey published 5,182 life sciences papers in peer-reviewed journals in 2010 – including Cell, Na-ture or New England Journal of Medi-cine and Science. Scientific output,

of course, also has other dimensions like education of the next generation of researchers but also, for example, the generation of patents for promis-ing new inventions. In 2010, the aca-demic and non-profit institutions in the sample filed a total of 45 patent applications. Clearly, this output re-quires significant and ongoing public funding – especially as research in the life sciences can be very time-con-suming and costly. The 16 institutions that provided LISAvienna with their financial data spent roughly EUR 699 million on the life sciences in 2010. Furthermore, 19 institutions received EUR 194 million for research projects in the life sciences last year.

Top Research Hot Spots in Vienna

In recent years, five science and tech-nology centers have emerged at vari-ous locations across Vienna where research institutions, hospitals and businesses co-locate. Dynamic start-ups and outstanding academic insti-tutes are concentrated at the Campus Vienna Biocenter, around the Vienna General Hospital which is one of Europe's largest hospitals, at Life-Science Vienna Muthgasse, on the 15-hectare campus of the University of Veterinary Medicine as well as at the Vienna University of Technology.

Universities Applied universities Non-profit research institutes Other Total

Number of employees in the life sciences (head count, end of 2010)

10,817 510 1,186 1,589 14,109

Number of students in the life sciences (winter semester 2010)

33,184 2,104 – – 35,288

Life science publications in peer-reviewed journals in 2010

4,430 24 387 341 5,182

Third-party funding spent in 2010 on life science (million euros)

150.0 0.6 35.1 8.4 194.1

academic institutions – Facts & Figures ii

Table 3

18 aCaDemiC DireCtory

academic Directory

academic institutes – alphabetical List

AGES – Austrian Agency for Health and Food SafetyFounded in 2002

The Austrian Agency for Health and Food Safety (AGES) is a government agency and a non-profit research organisation. AGES executes federal state tasks in the areas of agriculture, food and feed safety control, control of infectious diseases, veterinary medicine, radiation protection medical devices and pharmaceuticals. Focus of research is soil protection, agricultural production potentials (varieties, plant genetic resources, seeds, crop protection and plant health), GMOs, animal health, epidemiology of food-borne and infectious diseases, nutrition and risk assessment.

Employees: 1,428; 56% female Articles published: 72 Total budget: EUR 124.07 M

Third-party funding: EUR 1.56 M

Austrian Agency for Health and Food Safety (AGES)spargelfeldstrasse 191 1220 Vienna tel: +43-5-0555-0Fax: [email protected]

The dynamic development of the Vien-nese life science companies would not have been possible without the support of a first class academic infrastructure. With more than 35,000 students in 22 academic institutions in the life sci-ences alone, Vienna educates more young scientists than any other city in Austria. The bandwidth of the insti-tutes’ landscape is particularly large. It includes classical academic education at the University of Vienna as well as training in specialist disciplines in ba-

sic and applied research facilities. This extensive scientific range traditionally attracts a large number of national and international private companies that support research with large amounts of external funding or even completely self-financed institutions. Nu merous inno va tions owe their exis tence to this proximity between research and indus-try. The list below contains short por-traits and additional information on the life science institutes located in Vienna in alphabetical order.

types of institutions

Non-profit research institutes

Universities

Applied universities

Other

Vienna's Largest Life science institutions

University of Vienna

University of Natural Resources and Life Sciences, Vienna

Medical University of Vienna

University of Veterinary Medicine Vienna

University of Applied Sciences FH Campus Wien

Vienna University of Technology

University of Applied Sciences Technikum Wien

12,808

9,961

7,192

2,348

1,448

875

656

Institutions Students

Fig. 4: Distribution of different types of research institutes (see above)

Fig. 5: Size of the largest Viennese life science institutions in terms of students

45% (10)23% (5)

23% (5)

9% (2)

19aCaDemiC DireCtory

ABCSG – Austrian Breast & Colorectal Cancer Study GroupFounded in 1984

In the beginning was an idea: founded in 1984, the Austrian Breast & Colorectal Cancer Study Group (ABCSG) initially formulated its objective to effectuate sub-stantial improvements in the treatment of breast and colorectal cancer with high-level scientific activities. This objective has since been implemented – today, the ABCSG is one of the largest and most successful clinical trial groups in Europe.

Employees: 26; 92% female

Austrian Breast & ColorectalCancer Study Group (ABCSG)nussdorfer Platz 8 1190 Vienna tel: +43-1-4089230Fax: [email protected]

ACIB – Austrian Centre of Industrial BiotechnologyFounded in 2010

As an independent and interdisciplinary non-profit research company, ACIB con-ducts top level research in Vienna, Graz and Innsbruck. Under the slogan “In-novations from Nature,” ACIB makes use of the tools and concepts of nature for industrial production. Established at the location Life Science Vienna Muthgasse are the research areas Cell Design & Engineering and Bioprocess Engineering; further research areas of ACIB include Biocatalytic Synthesis, Enzymes for Poly-mers and Protein Design & Engineering.

Employees: 48; 57% female Articles published: 6 Total budget: EUR 3.56 M

Patents filed: 1 Third-party funding: EUR 0.14 M

Austrian Centre of Industrial Biotechnology (ACIB)muthgasse 11 1190 Vienna tel: +43-1-47654-8034tel: [email protected]

AIT – Austrian Institute of TechnologyFounded in 2009

The Austrian Institute of Technology (AIT) is Austria‘s largest non-university research institute and addresses unmet societal and industrial needs. Two of its five depart-ments place a strategic focus on life sciences: the AIT Health & Environment Depart-ment is focused on translational research in the fields of preclinical and clinical diag-nostics, prevention as well as the sustainable exploitation of biological resources. The AIT Safety & Security Department is making a significant contribution to the ICT dimension of life sciences. Software for medical telemonitoring, therapy manage-ment, movement analysis and brain signal investigation are being developed.

Employees: 257 Articles published: 93 Total budget: EUR 26.38 M


Austrian Institute of Technology (AIT)Donau-City-strasse 1 1220 Vienna tel: +43-5-0555-0Fax: [email protected]


BOKU – University of Natural Resources and Life Sciences, ViennaFounded in 1872 as k.k. Hochschule für Bodenkultur

The University of Natural Resources and Life Sciences, Vienna, the Alma Mater Viridis, links the natural sciences, engineering and economics. In this way, BOKU contributes to the protection of living space and quality of life, the management of natural resources and to securing nutrition and health. Biotechnology is one of BOKU‘s seven main research areas and is concentrated in the Vienna Institute of BioTechnology: At Muthgasse, research activities include biopharmaceutical technology and bioprocess engineering. Agro and environmental biotechnology are located in Tulln.

Employees: 2,207; 44% female Articles published: 496

Students: 9,961 Patents filed: 2 Third-party funding: EUR 30.39 M

University of Natural Resources and Life Sciences, Vienna (BOKU)Gregor-mendel-strasse 33 1190 Vienna tel: +43-1-47654-0Fax: [email protected]

CeMM – Research Center for Molecular MedicineFounded in 2000

CeMM, the Research Center for Molecular Medicine of the Austrian Academy of Sciences, is an international, independent and interdisciplinary research institute. “From clinic to clinic”: driven by medical needs, CeMM integrates basic research and clinical expertise to pursue innovative diagnostic and therapeutic approach-es. The main research interests focus on decoding molecular mechanisms related to cancer, inflammation and immune disorders, with the aim of creating a basis for the predictive, preventive and personalized medicine of the 21st century.



Research Center for Molecular Medicine (CeMM)Lazarettgasse 14, aKH Bt 25.31090 Vienna tel: +43-1-40160-70011Fax: +43-1-40160-970 [email protected]

CCRI – Children's Cancer Research InstituteFounded in 1988

The Children's Cancer Research Institute (CCRI) operated by the St. Anna Kinder-krebsforschung Association is a non-profit research institution that is solely fund-ed by volunteers' donations and competitive research grants. It was founded in 1988 with the overall aim of improving the treatment of malignant childhood diseases. The scientific focus is on basic laboratory, translational and clinical re-search – in close collaboration with the St. Anna Children’s hospital–, with special attention to leukemia and bone marrow transplantation as well as tumor biology and immu nology.

Employees: 93; 71% female Articles published: 64

Children's Cancer Research Institute (CCRI)Zimmermannplatz 1090 Vienna tel: +43-1-40470-0tel: [email protected]

Education & REsEaRch at thE samE placEVienna Institute of Biotechnology/University of Natural Resources & Life Sciences, Novartis, AIT/Austrian Institute of Technology, Themis, et al.

Print: CMYK 80-15-100-10 Muthgasse

LifeScience Vienna Muthgasse:Join the perfect location withstate-of-the-art infrastructure.

www.lifescience-vienna.com

ReSeaRch needS diaLoGue

flo

orf

ou

r ag

entu

r für K

omm

unik

atio

n


CDG – Christian Doppler ForschungsgesellschaftFounded in 1989

The Christian Doppler Research Association (CDG) supports application-oriented basic research in what are known as Christian Doppler Laboratories. These research laboratories are established for a maximum of seven years by highly qualified sci-entists in universities and non-university research institutions in collaboration with companies. In Vienna, 18 CD Labs can be assigned to the life sciences. Research topics range from food analysis, flavoring agents and cellulose chemistry to the medical field where allergies, cancer, heart diseases and immunological disorders and also laser technologies for medical purposes for example take center stage.

Christian Doppler Forschungs-gesellschaft (CDG)sensengasse 1 1090 Vienna tel: +43-1-504 2205Fax: +43-1-504 [email protected]

GMI – Gregor Mendel Institute of Molecular Plant BiologyFounded in 2000

The GMI was founded by the Austrian Academy of Sciences in 2000 to promote research excellence in the area of plant molecular biology. Research at the GMI is curiosity driven and covers many aspects of molecular genetics, including basic mechanisms of epigenetics, population genetics, chromosome biology, develop-mental biology and stress signal transduction. Arabidopsis thaliana is the primary model organism used – although other organisms are also studied.



Gregor Mendel Institute of Molecular Plant Biology (GMI)Dr.-Bohr-Gasse 3 1030 Vienna tel: +43-1-79044-9000Fax: [email protected]

IMBA – Institute of Molecular BiotechnologyFounded in 1999

IMBA uses model organisms and cutting-edge functional genomics to investigate fundamental molecular processes and their contribution to disease. In interdis-ciplinary research groups, IMBA pursues an integrative approach that combines functional screening, cellular RNAi, stem cell and imaging technologies with the knowledge for rapidly generating mouse disease models to examine the role of genes in physiology and pathogenesis. Numerous cooperations with leading aca-demic and industrial partners are an integral part of IMBA’s strategy and commit-ment to delivering outstanding results from its basic research.


Patents filed: 6

Institute of Molecular Biotechnology (IMBA)Dr.-Bohr-Gasse 3 1030 Vienna tel: +43-1-79044Fax: [email protected]


IMP – Research Institute of Molecular PathologyFounded in 1985

At the IMP, more than 200 scientists from over 30 countries carry out curiosity-driven, basic research in the molecular life sciences. Their projects are broadly or-ganized into four topic areas: life at the molecular and cellular levels, information processing and storage in neural circuits, mechanisms of organismal develop-ment and disease, and interdisciplinary approaches that bring ideas and methods from other fields to bear on biological questions. The common goal in all of these areas is to elucidate the mechanisms and principles that underlie complex bio-logical processes. All research results are published in refereed journals.


Patents filed: 2

Research Institute of Molecular Pathology (IMP)Dr.-Bohr-Gasse 71030 Vienna tel: +43-1-79730Fax: [email protected]

KLG – Karl Landsteiner GesellschaftFounded in 2004

The Karl Landsteiner Association is a non-profit research organization. It was founded in 2004, with the aim of accelerating patient-oriented scientific research in Vienna and Lower Austria. It is the largest medical research society in Austria; research is mainly performed at the premises of medical suppliers and is thus close to patients. The society covers a broad range of medical disciplines and results can often be implemented in daily routine with immediate benefits for pa-tients. The Institutes are chaired by highly eminent individuals. Quality assurance is performed by recurrent evaluation of the institutes.



Karl Landsteiner Gesellschaft (KLG)Franziskanergasse 4a 3100 st. Pölten tel: +43-676-5747531Fax: +43-2748-7303sekretariat@karl-landsteiner.atwww.karl-landsteiner.at

FOR

SCHUNG FORTSC

HR

ITT

FÖ R D E R U NG

LBG – Ludwig Boltzmann GesellschaftFounded in 1960

The LBG is a non-university research institution in the fields of human medi-cine and life sciences focusing on translational and clinical research as well as humanities. After a comprehensive restructuring in 2002, there are 20 Ludwig Boltzmann Institutes, and 5 Clusters today. Goal of this restructuring was to implement a high level of quality. New Ludwig Boltzmann Institutes are exclu-sively founded by means of a public call for proposals. Institutes are then set up for a period of seven years with the option of prolonging their runtime for another seven years.



Ludwig Boltzmann Gesellschaft (LBG)nussdorfer strasse 64, 6. stock1090 Vienna tel: +43-1-5132750Fax: [email protected]


MFPL – Max F. Perutz LaboratoriesFounded in 2005

The Max F. Perutz Laboratories are the research center for molecular biology of the University of Vienna and the Medical University of Vienna. With more than 60 research groups, the MFPL is the largest basic research institute on the Cam-pus Vienna Biocenter. Besides doing research, the institute’s second main focus is educating and training the next generation of scientists. The MFPL offer un-dergraduate studies, an international PhD program, post doc training and junior group leaders positions.



Max F. Perutz Laboratories (MFPL)Dr.-Bohr-Gasse 91030 Vienna tel: +43-1-4277-24001Fax: [email protected]

MedUni Vienna – Medical University of ViennaFounded in 1365 as the Medical Faculty of the University of Vienna

Medical University Vienna is the largest and most traditional medical institution in Austria. With 31 university departments and clinics, 12 centers of medical theory and a large number of highly specialised laboratories, it also ranks among the main European top research institutions in the field of biomedicine. 7,200 stu-dents and 2,300 teaching personnel on campus and in 13 training hospitals make it the largest medical training facility in the German-speaking area and one of the top training establishments in Central Europe.

Employees: 5,112; 55% female Articles published: 1,871 Total budget: EUR 270.00 M

Students: 7,192 Patents filed: 16 Third-party funding: EUR 74.58 M

Medical University of Vienna(MedUni Vienna)spitalgasse 231090 Vienna tel: +43-1-40160-0Fax: +43-1-40160-910 [email protected]

ofi – Austrian Research Institute for Chemistry and TechnologyFounded in 1946 as the association “Chemisches Forschungsinstitut der Wirtschaft Österreichs” (CFI)

ofi provides services for pharmaceutical products all over Europe, including pre-clinical development, preparation and release of active ingredients and drugs, as well as the development and testing of primary packaging. One focus of research is the interaction of polymers with the goods packaged, e.g. within extractables & leachables studies. Chromatographic Multimethods using mass spectrom-etry are developed for safety screening, along with in-vitro bioassays, to detect biological effects within compatibility studies.

Employees: 18; 33% female Total budget: EUR 2.32 M


Austrian Research Institute for Chemistry and Technology (ofi)Brehmstrasse 14a 1110 Vienna tel: +43-1-7981 601-0Fax: +43-1-7981 [email protected]


University of Applied Sciences FH Campus WienFounded in 2011, University of Applied Sciences status since 2004

The University of Applied Sciences, FH Campus Wien, cultivates an intensive exchange with research organizations, teaching, healthcare institutions and pri-vate industry and is thereby constantly improving the high scientific quality and practical relevance of the courses. FH Campus Wien cooperates in the fields of “applied life sciences” and “health” with the University of Vienna, the University of Natural Resources and Life Sciences, Vienna, the University of Veterinary Medi-cine Vienna and the Medical University of Vienna. Various research projects in these fields play an important part in FH Campus Wien R&D activities.

Employees: 480; 53 % female Articles published: 14

Students: 1,448

University of Applied Sciences FH Campus WienFavoritenstrasse 226 1100 Vienna tel: +43-1-6066877-6600tel: +43-1-6066877-6609office@fh-campuswien.ac.atwww.fh-campuswien.ac.at

University of Applied Sciences Technikum WienFounded in 1994

The University of Applied Sciences Technikum Wien is Austria's largest purely technical university of applied sciences. Research at the UAS is currently focused on embedded systems, renewable energy and life science technologies. The research activities in the field of life sciences cover a wide range, from projects in eHealth, tissue engineering, ambient assisted living and ambient assistive technologies to topics such as mechanical ventilation technology, rehabilitation technology, biomechanics and motion analysis.

Employees: 30; 23 % female Articles published: 10

Students: 656 Third-party funding: EUR 0.63 M

University of Applied SciencesTechnikum WienHochstaedtplatz 51200 Vienna tel: +43-1-3334077-0Fax: [email protected]

University of ViennaFounded in 1365 as Alma Mater Rudolphina

The University of Vienna was founded in 1365 and is the oldest university in the German-speaking world and one of the largest in Central Europe. Research and teaching in the life sciences are predominately at the core of three of its 18 facul-ties and centers – that is the Faculty of Life Sciences and the Center for Molecular Biology and the Faculty of Chemistry. A wide spectrum of scientific subjects rang-ing from immunology, molecular and organismic biology as well as pharmaceuti-cal and nutritional sciences, biodiversity and biochemistry is covered.

Employees: 1,874; 46 % female Articles published: 1,455

Students: 12,808 Third-party funding: EUR 22.56 M

University of ViennaDr.-Karl-Lueger-ring 1 1010 Vienna tel: +43-1-4277-0www.univie.ac.at


Vetmeduni Vienna – University of Veterinary Medicine, ViennaFounded in 1765

The University of Veterinary Medicine, Vienna (Vetmeduni Vienna) is the only uni-versity in Austria focusing on veterinary medicine. Cutting-edge infrastructure on campus and at a number of branches in and around Vienna support excellence in research, teaching and veterinary medicine. A special asset of Vetmeduni Vienna is its animal hospital that provides essential hands-on training for students. In addition, a number of spin-off companies have established their premises on the university campus.

Employees: 1,086; 59% female Articles published: 395

Students: 2,348 Third-party funding: EUR 7.42 M

University of Veterinary Medicine, Vienna (Vedmeduni Vienna)Veterinaerplatz 11210 Vienna tel: +43-1-25077-0tel: [email protected]

Vienna University of TechnologyFounded in 1815 as Imperial and Royal Polytechnical Institute

The Vienna University of Technology (TU Vienna) is among the most success-ful technical universities in Europe and is Austria‘s largest scientific-technical re-search and educational institution. Research areas cover all classic engineering disciplines, many of them are highly relevant for biotech and medtech industries. TU Vienna for example hosts expertise in bioanalytics and sensor development, biomechanics, biomedical engineering, chemical technologies, electrodynamics, material sciences and software development.


Students: 875 Patents filed: 8 Third-party funding: EUR 15.05 M

Vienna University of Technology Karlsplatz 13 1040 Vienna tel: +43-1-58801-0Fax: [email protected]

VRVis Center for Virtual Reality and Visualization ResearchFounded in 2000

VRVis is Austria's leading research company in the field of visual computing with a research group in medical visualization. Together with the Institute for Computer Graphics at the Vienna University of Technology and the visualization group at the Austrian Academy of Sciences, VRVis forms one of the largest computer graphics research groups in Europe. VRVis is an active partner for research initiatives of the federal government and the City of Vienna. Its higher aim is to strengthen the innovation and competitiveness of Austria.



VRVis Center for Virtual Reality and Visualization ResearchDonau-City-strasse 1 1220 Vienna tel: +43-1-20501-30100Fax: [email protected]

AWS-Report_Anzeige_A4_v1.indd 1 04.11.11 10:18

28 ComPanies

Life science Companies in Vienna

Dedicated biotech and biotech-active companies

Dedicated medtech and medtech-active companies

Life science related companies

Legend

Vienna is not only the economic and political center of Austria, but also the most

dynamic life science location in the country. Within the city borders the highest

concentration of life science companies in Austria can be found. Especially in bio-

technology Vienna is the leading cluster in Austria and is furthermore developing

into one of the leading clusters in medical technology.

For definitions of the categories refer to glossary on page 151.

29ComPanies

top 10 of Vienna's Life science Companies

1 Otto Bock Healthcare Products GmbH

2 Intercell AG

3 Affiris AG

4 Agfa HealthCare Ges.m.b.H.

5 VIVISOL Heimbehandlungsgeräte GmbH

6 Technoclone GmbH

7 NABRIVA Therapeutics AG

8 Avir Green Hills Biotechnology AG

9 TissueGnostics GmbH

10 Carl Reiner GmbH

Dedicated biotech and medtech companies sorted according to employee number

31

Biotechnology in Vienna – Facts & Figures

ComPany statistiCs

Biotechnology in Austria is among the industry sectors with the great-est future potential. In the last ten years, a lively scene has developed nationwide with Vienna hosting 61 companies. As shown in Tab. 4, the capital is home to 43 companies that are completely dedicated to biotech-nology (called dedicated companies, see OECD definition p. 151). They have been attracting attention since day one – particularly in the most demanding discipline of biotechnol-ogy: the development of new drugs. Around 70% of all Vienna-based bio-tech companies are active in this field (see Fig. 6). Other operations com-prise largely various services in the life sciences field or industrial and agricultural biotechnology R&D.

Alongside the dedicated companies, there are 18 in some cases consider-ably larger companies in which bio-technology represents one of several activities. They are referred to here as biotechnology-active companies. The subsidiaries of international pharmaceutical companies such as Baxter, Boehringer Ingelheim or Eli Lilly, which fall into this category, can be consid-

ered as the nucleus out of which Aus-tria's modern biotech industry arose.

Dynamic Start-up Scene

In recent years, the news coming out of Vienna has been predominantly posi-tive. Enterprises such as the vaccine specialist AFFiRiS, the cancer experts at Apeiron or the next generation anti-body company F-star have made inter-national names for themselves due to excellent clinical results and licensing agreements with leading pharmaceuti-cal companies. The fertile climate also attracts newcomers such as PDC Bio-tech which moved to Vienna from Can-ada in 2008 to develop drugs against preterm labor. Most recently (and after this survey was concluded), the vaccine developer Hookipa Biotech managed to pocket some of the rare early-stage venture capital. Renowned internation-al investors like Sofinnova Partners or Forbion brought in more than 7 million euros in the first financing round.

Most biotech companies engage in the field of health/medicine but numer-ous companies are also active in areas apart from drug development (see Fig.

Biotechnology in Vienna – Key Figures 2010Total number of primary biotechnology companies......................................................................................................................61

Number of dedicated biotechnology companies .............................................................................................................. 43

Number of other biotechnology-active companies (e.g. pharma, chemicals or seeds manufacturers) ...........................18

Total number of employees (headcount) in primary biotechnology companies ......................................................................7,498

Number of employees in dedicated biotechnology companies .................................................................................... 848

Number of employees in biotech-active companies ................................................................................................... 6,650

Total revenues of primary biotechnology companies ....................................................................................................EUR 883 M

Revenues of dedicated biotechnology companies .............................................................................................. EUR 97 M

Revenues of other biotechnology-active companies ......................................................................................... EUR 786 M

R&D expenditure of dedicated biotechnology companies ........................................................................................... EUR 146 M

Total amount of financing raised by dedicated biotechnology companies ..................................................................... EUR 58 M

23 % (10)

areas ofactivity

Health/medicine (incl. animal health)

Non-specific services

Industrial biotechnology

Agricultural biotechnology

5 % (2) 2 % (1)

70 % (30)

Fig. 6: Distribution of activity fields of Viennese dedicated biotech companies

Table 4

32 ComPany statistiCs

Clinical Pipeline

be seen in the mostly established bio-tech-active companies which earned approx. 786 million euros in 2010 (see Tab. 4). Together with the sales earned by dedicated companies, Vienna has the one billion mark in revenues in sight. Positive developments like these are honored by investors. Last year, 58 million euros of capital flowed into Vienna-based biotech companies. 14 million euros of this came from venture capital firms, another 28 million euros came from other private sources like business angels. By now, the indus-try sector has reached a critical mass, which means that it can also cope with development setbacks in individual companies and survive without crip-pling damage.

Strong Investment in Research and Development

In 2010, the dedicated biotech compa-nies spent 146 million euros on research and development. Thus, the investment is 1.5 times higher than the yearly sales achieved by dedicated biotech firms. This shows that the industry is still young, but furthermore it demonstrates that a considerable amount of capital

Biologics

Small Molecules

0

25

6

11

2

9

0 0 02

6). Good examples are Mycosafe or Vi-rusure. Both companies are spin-offs of the University of Veterinary Medi-cine in Vienna and operate today as successful specialists for in-vitro test-ing of bacteria or viruses and prions. Furthermore, EUCODIS Bioscience is an enzyme engineering company with customers in the phar ma ceutical, bio-tech no logy, diagnostics and other in-dustries. The firm manu factures and markets more than 50 well-character-ized enzymes worldwide.

Turnover: 1 Billion Euro Mark in Sight

The average age of a Viennese bio-technology company is only 7.1 years (see Fig. 7). Due to their youth and highly research-oriented nature, the dedicated companies generated sales of 97 million euros which is relatively insignificant when compared to other future industries such as IT or medi-cal technology. However, the special business model of the biotechnology companies with its long development times has been understood in Vienna: Long-term development of the bio-technology sector is being encour-aged. Where this route may lead can

25

20

15

10

5

0

preclinical

Phase I

Phase II

Phase III

Approved

Fig. 8: Number of therapeutics under development of Vienna-based, dedicated biotech companies

average age:7.1 years

agestructure

2008 – 2010

< 2002

2005 – 2007

2002 – 2004

30% (13)21% (9)

26% (11)23% (10)

Fig. 7: Distribution of Vienna-based dedicated biotech companies according to their founding year

33ComPany statistiCs

has been raised from venture capital as well as from cooperation agreements with pharma ceutical companies to build a strong pipeline of R&D projects which is the basis for future commercial success.

Biotech “Made in Vienna” –

22 Products in Clinical Development

Two biopharmaceutical products de-veloped in Vienna are currently on the market: an anti-viral nasal spray against the common cold, developed by Mari-nomed, and a vaccine against Japa-nese Encephalitis, developed by Inter-cell. Nine further biological agents are expected to demonstrate their efficacy for patient therapy in clinical phase II. Among them is a compound against serious skin infections and bacterial pneumonia caused by drug-resistant bacteria, developed by Nabriva. Final-ly, there are 13 components (see Fig. 8) in phase I. Companies like Apeptico are at this stage. More than 30 com-pounds could be added to the clinical pipeline in coming years if the preclini-cal projects clear further development hurdles. In total, the “Vienna pipeline” of the dedicated companies amounts

to 55 active ingredient projects. This is a number that corresponds well to the amount of projects carried out by a big pharmaceutical company. After conclusion of the survey, Apeiron ac-quired a phase III in the indication of neuroblastoma in children.

Nearly 7,500 Jobs in Biotechnology

Overall nearly 7,500 people are em-ployed in the biotech industry in Vienna, of which 848 people work in dedicated and 6,650 people in biotech-active companies (see Tab. 4). The proportion of women among employees in dedi-cated biotech companies is 56%, much higher than in almost any other high-tech sector (see Fig. 10). As elsewhere in Europe, the biotech companies in Vienna are relatively small. As shown in Fig. 9, almost half employ less than ten people – expensive, know-how in-tensive services such as the set up and execution of clinical trials or manage-ment of the patent portfolio are typically outsourced. This in turn provides fertile ground for specialized service provid-ers that have also settled in the capital. Every fifth biotech-active company be-longs to this group.

Company Drug candidate Indication

Activartis Trivax Renal cell carcinoma

AFFiRiS AG AD02 Alzheimer‘s disease

Apeiron AGAPN201APN01

Inflammatory skin conditionsAcute Respiratory Distress Syndrome (ARDS)

Avir Green Hills Biotechnology AG deltaFLU Influenza

Intercell AGIC43IC41

V710 (terminated)

Pseudomonas aeruginosa infectionsHepatitis C

Nosocomial infections (Staphylococcus aureus)

Marinomed Biotechnologie GmbH MAM-06.301 Type 1 allergy and autoimmune diseases

Nabriva BC-3781Antibiotics for serious infections caused

by resistant pathogens

Drug Candidates in Phase ii

Approved

Fig. 9: Size structure of Vienna-based dedicated biotech companies according to their staff

employee structure< 10 50 – 99

10 – 49 100 – 249

44% (371)

Male

56% (477)

Female

2% (1)5% (2) 49% (21)

44% (19)

Fig. 10: Proportion of male and female employees in Vienna‘s dedicated biotech firms

Table 5

BioteCH sUCCess stories

Vienna-based AFFiRiS AG is one of the world’s leading pioneers in the develop-ment of vaccines against widespread diseases. It’s innovative platform – the AFFITOM© technology – enables it to develop custom-designed vaccines against the body’s own proteins which are at the center of chronic conditions such as Alzheimer‘s disease, Parkin-son’s disease, arteriosclerosis or hy-pertension.

Blockbuster Vaccines

AFFiRiS first attracted attention in 2008 with a large-scale licensing deal. The British pharmaceutical company GlaxoSmithKline signed a contract worth a total of 430 million euros giving it the rights to the two most advanced Alzheimer’s vaccines developed by AFFiRiS. Both partners have since made such good progress that the li-censing agreement has been extended to include another vaccine developed by AFFiRiS. Having achieved the prima-ry study objective of running two phase I trials at once, AFFiRiS AG was able to demonstrate the safety and the excel-lent tolerance of the two Alzheimer’s

vaccines AD01 and AD02. What was particularly remarkable was that initial indications of efficacy were already showing up. A phase II study with AD02 is currently running in several Europe-an countries. The intention is to treat 420 patients in all. However, develop-ing active ingredients for Alzheimer’s is not the only project AFFiRiS is involved in. The pipeline is full to bursting. There are more than ten other vaccines in de-velopment. The preclinical studies for Parkinson’s and arteriosclerosis are al-most complete and the clinical phase I trials are scheduled to start. Develop-ment of the Parkinson’s vaccine PD01 was even awarded a financial grant by the prestigious Michael J. Fox Foun-dation in October 2011. Development successes have repeatedly made it easy for the company to attract capi-tal. So far, however, the company has stayed faithful to one investor. MIG Fonds, the leading specialist for ven-ture capital in the German-speaking countries, has invested 11.5 million euros in the company since it was set up. Substantial public funding was also provided by austria wirtschaftsservice, FFG and ZIT.

Walter schmidttogether with his partner Frank Mattner, set up AFFiRiS AG which has been managed by both since 2003 and it was no accident that they chose Vienna. Following his doctorate, Schmidt worked on research in Max Birnstiel’s team at the Institute of Molecular Pathol-ogy in Vienna. He was already a founder member of Intercell AG in 1998.

aFFiris aG

Category .......................................................... Health/medicine

Foundation ......................................................................... 2003

staff ....................................................................................... 80

34


Vienna’s APEIRON Biologics AG has al-ready worked wonders in only five years. Out-licensing, in-licensing, a pipeline spanning preclinical to phase III projects – the company has already achieved all of this even though it only started opera-tions in early 2006. At the same time, the management, led by chief executive of-ficer Hans Loibner, pays strict attention to capital efficiency. So far, the company has been financed by private investors and employees as well as from public funding from aws, FFG and ZIT. In ad-dition, they closed a licensing contract with GlaxoSmithKline (GSK) in February 2010, which could earn Apeiron up to 236 million euros. In the course of this deal, GSK also became a shareholder of Apeiron. GSK has already transferred 12.5 million euros of this in advance and received the rights to APN01, an enzyme that could be used in the treatment of acute respiratory distress syndrome and a variety of other diseases. The concept was initially researched in the laboratories of Josef Penninger, scien-tific director of the Institute of Molecular Biotechnology at the Austrian Academy of Sciences (IMBA) in Vienna. The ge-neticist is a co-founder and major share-

holder of Apeiron. It was his idea to fight acute respiratory distress syndrome with recombinant ACE2. Nowadays, the angiotensin-converting enzymes are linked mainly to the regulation of blood pressure. The intention of current clini-cal studies is to demonstrate that their potential is far from exhausted.

Apeiron has subsequently in-licensed new clinical projects to complement its pipeline. In the process, the company took over the recombinant human en-zyme SOD, status phase II, from Poly-mun Scientific GmbH. SOD is about to enter a clinical trial for the topical treat-ment of skin damage following radiation therapy as a part of cancer treatment. Apeiron also made use of its connec-tions to Big Pharma. As a result, it ac-quired an antibody-IL2 fusion protein for the treatment of neuroblastoma in chil-dren from the German Merck KGaA. The last cooperation that Apeiron entered into was with St. Anna Children’s Cancer Hospital in Vienna for an antibody in the same indication but with a different sub-set of patients. The phase III project in-volves study centers in 20 countries. 160 children have already been recruited.

aPeiron Biologics aG


Foundation ......................................................................... 2006

staff ....................................................................................... 21

Hans Loibnerhas been CEO of APEIRON Bio-logics AG in Vienna since October 2005. He has 35 years experience working both in Big Pharma and Biotech, with a focus on cancer immunotherapy. After spending 20 years in the R&D management of Sandoz and Novartis, he set up the cancer immunotherapy spe-cialist Igeneon in 1999 and acted as CEO until mid 2004.

35


Fighting flu where it enters the human body. This is the aim of AVIR Green Hills Biotechnology AG which is de-veloping next generation influenza vaccines. The motto: “A nasal vaccine spray instead of injection”. In April, the company started a trivalent phase I/II trial during which the seasonal influ-enza vaccine was tested for the first time in its final composition.

Fighting the Flu!

80 volunteers between the ages of 16 and 60 were included in the study. The trial was conducted at the De-partment of Clinical Pharmacology at the Medical University of Vienna and included a trivalent formulation – this means a vaccine comprising three in-fluenza strains H1N1, H3N2 and B. In the clinical trial, AVIR Green Hills uses its particularly efficient live-attenuat-ed deltaFLU vaccine from which the pathogenicity factor NS1 has been removed. This approach combines maximum efficacy with excellent safety and tolerance. This has already been demonstrated in previous clini-cal trials. The vaccine was produced

in cell cultures, a modern method that replaces the traditional production method using hens’ eggs.

Leading European Specialist

AVIR Green Hills is also well-connect-ed at an international level. In the Eu-ropean Commission’s 6th Framework Program, the company led the FLU-VACC consortium which received 9.2 million euros of funding for the devel-opment of an intranasal nasal influenza vaccine. Alongside the public funding, which included a recent grant of 1.6 million euros from the Austrian Re-search Promotion Agency (FFG) and substantial financing from aws and ZIT, the research work of AVIR Green Hills is mainly financed by business angels.

A new round of financing was only completed last year. Additionally, there are advanced activities to con-clude licensing contracts for the in-tranasal vaccine deltaFLU in several territories. With reports of success like this in the bag, AVIR Green Hills is an attractive candidate for investment and for commercial success.

aVir Green Hills Biotechnology aG


Foundation ......................................................................... 2002

staff ....................................................................................... 40

thomas musteris the Chief Executive Officer, founder and scientific manager of AVIR Green Hills Biotechnology AG. After starting his scientific career at the University of Natural Resources and Life Sciences in Vienna, Thomas Muster was drawn to the Mount Sinai School of Medicine in New York where he worked on retroviruses such as HIV and influenza viruses.

36


Company founders from North America don't often find their way to Europe. Diane Kalina and Patricia Griffin made an ex-ception in this case: PDC Biotech GmbH which they set up in Vienna has brought them success in the federal capital. The two managing directors were working as consultants in the biotechnology sector in Canada and among their clients was Theratechnologies Inc.

Preventing Premature Labor

The company wanted to concentrate on its Phase III project and so was on the lookout for a buyer for a very promising earlier stage technology; a peptide that can prevent preterm labor and painful uterine contractions during menstruation. Premature births are among the great-est peri natal challenges in industrialized countries. They are usually preceded by preterm labor. The prostaglandin F2α-receptor antagonist is intended to pre-vent this. So far there are no alternative treatments that are effective and safe for the fetus and mother. Along with emo-tional stress and the risk to the child’s life, preterm births cause significant costs. Experts assume these to be in excess

of 25,000 euros which is what it costs to treat a premature baby. Kalina and Griffin identified the need, in-licensed the drug candidate PDC31 and set up PDC Bio-tech in Vienna. Seed financing was suc-cessfully obtained by aws. With a set-up grant of 1 million euros, the founding team was able to inspire prestigious in-vestors. Edmond de Rothschild Invest-ment Partners and MIG invested ap-proximately 4 million euros shortly after the set-up. Furthermore, PDC received funding by ZIT in the framework of the call “Patients in Focus 2009”.

Using the funds from the Series A round, the company is now completing a Phase I trial to assess safety as well as effects on uterine contractility in healthy women with primary dysmenorrhea. The results should ultimately impress and attract fur-ther investors for a Series B round. The company's immediate aim post-Series B, is to advance PDC31 to the next stage of development – Phase II – and study the effects of PDC31 in pregnant women with preterm labour. The goal is to deter-mine whether PDC31 can inhibit uterine contractions halt the progression of pre-term labor to protect young life.

PDC Biotech GmbH


Foundation ..........................................................................2008

staff ......................................................................................... 4

Diane Kalina and Patricia Griffinare the founders and managing directors of PDC. During their careers both have gained expe-rience in management positions with leading pharma companies on both sides of the Atlantic. Prior to starting up PDC, both co-founders worked as consultants for pharmaceutical and biotech companies.

37

39

medtech in Vienna – Facts & Figures

ComPany statistiCs

medtech in Vienna – Key Figures 2010Total number of primary medtech companies ............................................................................................................................. 38

Number of dedicated medtech companies ...................................................................................................................... 33

Number of other medtech-active companies ..................................................................................................................... 5

Total number of employees (headcount) in primary medtech companies ..............................................................................1,661

Number of employees in dedicated medtech companies ..............................................................................................831

Number of employees in the medtech-active companies .............................................................................................. 830

Total revenues of primary medtech companies .............................................................................................................EUR 835 M

Revenues of dedicated medtech companies .....................................................................................................EUR 116 M

Revenues of other medtech-active companies ................................................................................................. EUR 719 M

R&D expenditure of dedicated medtech companies ...................................................................................................... EUR 30 M

Total amount of financing raised by dedicated medtech companies ................................................................................ EUR 5 M

The healthcare system in Austria enjoys an excellent international reputation. This is due not least to the renowned hospitals located in the country's capi-tal Vienna which have both superbly qualified medical staff and first-class technical facilities incorporating state-of-the-art technology. As a result, Aus-tria and especially Vienna create not only an attractive market for medical technology products but also form an important location for the development and production of several medical de-vices. This activity is based on a long, in some cases centuries old tradition of engineering and precision mechan-ics in the city's companies.

Medical devices, as defined by the Global Medical Devices Nomencla-ture Agency (GMDN), are the main products of the 33 dedicated medi-cal technology companies resident within the city limits of Vienna (see Tab. 7). Examples are Braincon Tech-nologies Group (electromechanical and e-health solutions) or Orthorobot GmbH (dental technology). They are involved exclusively in research, de-velopment and manufacture of these devices. In another five Vienna-based

companies, medical technology is one of several areas of work. Among these are Sempermed GmbH (gloves) or Telecare Systems GmbH (emergency call systems). These firms are called medtech-active companies according to the OECD classification for biotech firms that is also applied here to medi-cal technology.

Broad Range of Activity

The areas of activity pursued by the medical technology companies are very varied (see Tab. 6). Three areas dominate: firstly the development of specialized software and other prod-ucts for the trend areas of eHealth and telemedicine, secondly the production of precision electromechanical devices for patient monitoring, surgery, care or rehabilitation, and thirdly, a large number of Viennese medtech compa-nies are active in research, develop-ment and sale of consumables for day-to-day hospital use.

Innovations by New Companies

Vienna as a location is also a breeding ground for up-and-coming medtech

areas of activity*Software for medicine, telemedicine and e-health

41 %

Electromechanical medical devices 36 %

Consumables 27 %

Dental technology 9 %

Diagnostic and therapeutic radiation technology

9 %

Reusable and surgical instruments 9 %

Technical aids for invalids 9 %

Active implantation technology 5 %

Anesthesiology and ventilation 5 %

Hospital equipment 5 %

In-vitro diagnostics 5 %

Non-active implantable technology 5 %

Ophthalmic and optical technologies 5 %

Means based on biological materials 0 %

Others 0 %

* multiple answers possible by dedicated medtech companies

Table 6

Table 7

40 ComPany statistiCs

Company Global Sales Sales Rank

Johnson & Johnson 16,5 #1

Siemens Healthcare 12,1 #2

GE Healthcare 11,2 #3

Medtronic 10,2 #4

Baxter International (Medtech and Biotech) 8,8 #5

Philips Healthcare 7,8 #6

Abbott Laboratories 5,9 #7

Boston Scientific 5,7 #8

Not present in Vienna

Covidien 5,4 #9

Becton Dickinson 5,0 #10

8 of top 10 World market Leaders Present in Vienna

companies. As shown in Tab. 9, fur-ther companies were established last year such as MySugr Apps, which is working on a new format for monitor-ing diabetes via mobile phones. Jeder GmbH has dedicated itself to a new dental device. Another 2010 start-up is Vasema GmbH, a developer of new sensors for determining skin health. It will be exciting to see when these new products made in Vienna will be used in hospitals for the patient's good.

These young medtech firms comple-ment the group of global players like Otto Bock or Agfa Healthcare that are active in Vienna. With their almost cen-tury-old, longstanding tradition, Carl Reiner or Franz Kacer & Sohn GmbH are an exception to the Vienna scene. More than half the firms – more pre-cisely 58% – were set up less than ten years ago (see Fig. 11). One of them is EMCOOLS Medical Cooling Systems AG, founded in 2005. The enterprise has developed a single use cooling de-vice, which is adherent to the patient’s skin. The so-called EMCOOLSpad is highly adjustable during the cooling procedure. The company’s aim is to be-

come the leader in homecare applica-tions for skin cooling. Founded in 2008, Miracor GmbH is also a representative of the younger group among dedicated medtech companies. The firm devel-ops a new standard of care for cardiac diseases. These younger start-ups complement a significant proportion of enterprises (18%) ranging between 10 and 20 years of age. The average age of a Vienna-based medical technology company is 17.9 years.

Global Market Leaders in Vienna

For most of the global medtech players Vienna is too important to be missed. Only two of the world’s top 10 are not present in the federal capital. All the oth-ers – among them the market leaders Johnson & Johnson, Siemens Health-care and GE Healthcare – have a local subsidiary which enriches the medtech scene in Vienna and reinforces its inter-national standing (see Tab. 8).

800 Million Euros in Revenues

Overall, the sale of medical devices in the federal capital generates more

1980 – 1989

average age:17.9 years

age structure2000 – 2010 < 1960

1990 – 1999

1960 – 1969

1970 – 1979

9% (3)

18% (6)

3% (1) 3% (1)

9% (3)

58% (19)

Fig. 11: Distribution of Vienna-based dedicated medtech companies according to their founding year

Table 8

41ComPany statistiCs

than 800 million euros (see Tab. 7). Around 116 million euros of this sum is attributable to the group of dedicated medical technology companies (see definition on p. 151). The sometimes considerably larger medtech-active companies like Carl Zeiss produce total revenues of 719 million euros in Vienna.

Short Development Times

In contrast to biotechnology, medical technology is characterized by sig-nificantly shorter development times and – generally speaking – a lower development risk combined with a lower attrition rate. This can be seen above all in the ratio of investment in research and development to turno-ver.

With the 116 million euros in sales already referred to, they are generat-ing revenue that is approximately four times higher than their R&D expendi-ture of 30 million euros. Viennese medtech companies spend more on R&D than their counterparts in the rest of the country. The venture capi-

tal investment amounted to around 5 million euros in 2010.

1,600 People in Dedicated Firms

Like their counterparts in the biotech-nology industry, the medical tech-nology companies are also relatively small in terms of staff. Well in excess of half (58%) of the firms employ less than ten people (see Fig. 12), which is typical for many high-tech indus-tries. However, with a share of around one third (36%), a large number of the companies have already left the most difficult decade of their early existence behind them. All together, the medtech firms in Vienna employ about 1,660 people. Half of them work at the dedicated medtech companies and the other half in the group of medtech-active companies. Male employees dominate the medi-cal technology area (see Fig. 13), although not as heavily as in com-parable sectors such as information technology or mechanical engineer-ing. The proportion of female employ-ees is 41 %.

medtech Companies Founded 2010 in Vienna

MySugr Apps OG: The team develops software to help diabetes patients collect their personal data electronically and store

them on mobile phones by means of a “serious social game”.

Jeder GmbH: The company is engaged in the development of a device, which makes the implanting of artificial teeth easier and

safer – for both the doctor and the patient.

VASEMA GmbH: Vasema develops a high-tech sensor to diagnose skin diseases early. This will increase the chances of re-

covery and reduce healthcare costs.

8 of top 10 World market Leaders Present in Vienna

59 % (490)

Male

41 % (341)

Female

employee structure< 10

10 – 49

50 – 99

> 249

100 – 249

3% (1)3% (1)

58% (19)36% (12)

0%

Fig. 12: Size structure of dedicated medtech companies according to their staff

Fig. 13: Proportion of male and female employees in Vienna‘s dedicated medtech firms

Table 9

meDteCH sUCCess stories

The Reiner family was working in the Austrian capital city of Vienna as surgi-cal instrument manufacturers as long as 150 years ago. Today, the roots of Carl Reiner GmbH reach almost as far back into the past with its predecessor having been established in the heart of Vienna's hospital and university quar-ter in 1912. Carl Reiner's building in the Mariannengasse is still the company's headquarters but other buildings in Vienna and the site in Graz have been added in the meantime and reflect the company’s growth.

From Tonsil Compressors …

Since it was set up, the Carl Reiner company has dedicated itself to the construction and development of state-of-the-art surgical instruments and equipment. What started back then with the manu facture of tonsil compressors based on Dr. Haslinger's model, reached its provisional peak in 2005 with the innovative Twinstream respirator.

The old-established Viennese com-pany took the plunge into the global market with the first microprocessor-

controlled unit for jet ventilation. The special ventilation technique was re-searched by Carl Reiner in cooperation with the ENT clinic of Vienna’s General Hospital (AKH) – Europe's largest hos-pital – and other partners. The special feature of this innovative procedure is that it enables patients to be ventilated without a separate air tube.

The space gained as a result is partic-ularly important during operations on the lung or trachea when surgeon and anesthetist have to share access to the patient. Now, thanks to integrated pipes and nozzles, the apparatus can take the respiratory air directly to the patient.

… to High-tech Respirators.

With its broad product range, Carl Reiner GmbH is also widely recognized to be a skilful contact in widespread indications such as cardiology and urology. The Viennese medical tech-nology specialist now carries out the planning of complete medical facilities and offers integrated system solutions to achieve the aim becoming a single-source supplier for its customers.

Carl reiner GmbH

Category ....................................... medical Device Development

Foundation .......................................................................... 1912

staff ....................................................................................... 30

Peter rosseggerhas been the managing director of Carl Reiner since March 2011. He joined the company in 1988 for the first time and then left it in 1990 for a period of five years to pursue other opportunities in the medtech area. After his return in 1995, Peter Rossegger estab-lished the international marketing and distribution of the company's innovative jet ventilator system TwinStream.

42


Since it was set up in 2003, CRYPTAS it-security GmbH has specialized in the development of security solutions in the field of electronic healthcare systems. The company focuses, among other things, on solutions in the eHealth sec-tor which allow feasible management of asymmetric encryption systems.

eHealth is more than just the use of IT in healthcare. By networking informa-tion and processes, additional benefits are provided for the patient and the health service provider. The only obsta-cle is: data security. Health data is one of the most sensitive information and, therefore, has to be protected in the best possible manner with IT security technologies. The innovative software CAVE (Card Authetication Virtualization Environment), developed by CRYPTAS has recently been supporting the elec-tronic administration of the Statutory Health Insurance for Dentists in West-phalia-Lippe: the intelligent Smart Card System makes online billing easier and saves time, money and effort for ser-vice. Digital certificates on smart cards can be used for strong user authentica-tion, digital document signature and of course also for the encryption of sensi-

tive information – all are crucial for to-day's eHealth applications. Security and protection of data privacy must not be seen as cumbersome features – they are critical for establishing trust which is the basis for user acceptance. Although smart card technology was always con-sidered to be secure, it was also labeled user-unfriendly, the second major suc-cess factor for user acceptance. CRYP-TAS has solved this problem by devel-oping a clientless smart card concept. CAVE enables smart cards to be used without the need for previously installed software. Instead, the processes are outsourced to a central environment that can be made very secure. As a re-sult, users no longer need to deal with complicated technical processes and can use the system immediately and without prior knowledge. It is enough to simply connect via the web browser to the online service by employing a user-friendly plug & play technology and in-sert the chip card. CRYPTAS received support from ZIT during the develop-ment of CAVE. The IT company devel-oped this system on its own and fully researched the technology behind it as part of the ZIT-Call “Patients in Focus 2009” funding project.

CryPtas it-security GmbH

Category ........................................................................ eHealth

Foundation ......................................................................... 2003

staff ....................................................................................... 15

43

stefan Bumerl is managing director of CRYPTAS

it-security GmbH which he set

up in 2003. He has worked in

the field of data security, strong

authentication and smart cards

for over 15 years and is acknowl-

edged nationally and internation-

ally as an expert in this sec-

tor. He and his company have

implemented many projects for

protecting digital identities.


Miracor Medical Systems is one of the younger companies in Vienna’s medical technology scene. It was founded in May 2008 with capital backing from Earlybird and Delta Partners. The company wants to establish a new standard of care to treat cardiac diseases such as heart at-tack and heart failure using the PICSO technology. This concept was con-ceived by Miracor’s founder and Chief Scientific Advisor, Prof. Werner Mohl, who is a practising cardiac surgeon at the Medical University of Vienna.

Patients recovering from an intervention-al procedure can benefit from the Pres-sure-controlled Intermittent Coronary Si-nus Occlusion (PICSO) technology. The system consists of an innovative cardiac catheter and a control unit. This unit is used for controlled inflation and deflation of the balloon at the catheter tip. After treating a heart attack using a stent, the CE-marked unit is used to intermittently block the coronary sinus venous blood in a controlled manner thus improving the microcirculation in the compromised cardiac tissue. In around 350,000 heart attack patients in the USA and Europe, the microcirculation in the heart muscle is less than optimal even after the actu-

al blockage in the arterial blood vessel has been removed. Initial clinical trials in March 2011 showed that PICSO has the potential to reduce ischemia in these patients. The plan now is to corroborate the results in the broader-based, multi-center RAMSES study. The concept has impressed the German venture capital-ist fund SHS which was the lead investor in Miracor’s second financing round in September 2011. Since its foundation in May 2008, Miracor has secured a total of 14.9 million euros in venture capital and grants to develop the company. Full Eu-ropean market launch of PICSO will start in the second half of 2013. For Miracor this would be the impulse to make the leap across the Atlantic.

The outcome of the multi-center RAMSES trial will lay the foundations for establishing European sales and re-imbursement. Europe will be the test market for the new technology provid-ing both clinical and commercial proof of concept. Several leading medical device corporations are seeking medical devic-es which address the big unmet clinical need which Miracor is targeting. This exit route has lately proven to be very profit-able for medtech investors.

miracor medical systems GmbH

Category ....................................... medical Device Development

Foundation ......................................................................... 2008

staff ....................................................................................... 11

Jon H. Hoemhas been CEO of Miracor since the company was founded in May 2008. He has 23 years of experience of advanced medical devices in cardiology and cardiac surgery. Prior to joining Miracor, he was Senior R&D Engineer at GE Vingmed Sound, Vice President of Sales&Marketing in Medi-Stim and VP Europe for the US medical technology company AtriCure.

44

45meDteCH sUCCess stories

The pathologist’s experience still comes up trumps when evaluating blood and tissue samples. The quanti-tative analysis of different cell types in blood or tissue is determined by a labo-ratory employee who counts the cells. A shortage of qualified staff and an in-creasing number of analysis samples challenge laboratory systems of today.

Automating Blood Sample Analysis

Vienna-based TissueGnostics GmbH has set itself the target of automating these processes with a new software program thereby revolutionizing the analysis of blood and tissue samples. Having machines carry out the analysis of tissue samples and pre-classification of leucocytes on blood slides sounds much easier than it really is. Georg Steiner and Dr. Rupert Ecker, the pres-ent managing directors of TissueGnos-tics, researched the basic principles of the technology 10 years ago. They set up TissueGnostics in 2003 and a year later presented the technology to doctors for the diagnosis of prostate cancer in tissue samples. The require-ments are a high-power microscope and a software program which uses a

specially developed algorithm to iden-tify and display pathogenic patterns in cells. With TissueFAXS, HistoFAXS and HemoFAXS, TissueGnostics markets three different systems for analysing tis-sue, stained tissue sections and blood samples. The products are already be-ing marketed globally with the help of distributors. The company has its own branches in the USA and Romania. The international expansion was financed by the Wiener Wachstumsfonds which has an almost 50 % stake in the com-pany. The best argument in favor of the TissueGnostics systems is the saving in time: Once the slides are on the mi-croscope, the rest is plain sailing.

Large Number of Applications

What used to be laborious detail work now takes place automatically with a minimum of time and effort. The system is also completely objective. Analyses can be saved and assessed retrospec-tively. The systems developed by Tis-sueGnostics have already proven their suitability in a large number of practi-cal applications in facilities around the world, like the Harvard Medical School and University of Heidelberg.

tissueGnostics GmbH

Georg steinertogether with Rupert Ecker, manages the medical technology company TissueGnostics GmbH. The two biologists Steiner and Ecker already worked together at Vienna’s University Clinic in the mid-nineties and since then have dedicated themselves to improv-ing medical microscopy which also includes the setting up of TissueGnostics in 2003.

Category .......................... software and Hardware Development

Foundation ......................................................................... 2003

staff ....................................................................................... 35

47LiFe sCienCe DireCtory

Biotech dedicated Biotech active Medtech dedicated Medtech active Life science relatedB b M m R

ACompany Directory

ABA – Invest in AustriaOpernring 3

1010 Vienna

Tel.: +43-1-5885-80

Fax: +43-1-5868-659

[email protected]

Abbott GmbHPerfektastrasse 84A

1230 Vienna

Tel.: +43-1-891-120

Fax: +43-1-891-1244

Sector of activities: sales

www.abbott.at

ABF Pharmaceutical Services GmbHAltmannsdorfer Strasse 104

1120 Vienna

Tel.: +43-1-8901-200-0

Fax: +43-1-8901-200-11

Founded: 2005

Staff: 20

Working fields: human health

Sector of activities: services, sales

www.abf-pharma.com

M RB

M RB

M RB

ACR – Austrian Cooperative ResearchHaus der Forschung

Sensengasse 1

1090 Vienna

Tel.: +43-1-2198-573

Fax: +43-1-2198-573-13

[email protected]

M RB

48 LiFe sCienCe DireCtory


AActivartis Biotech GmbHZimmermannplatz 10

1090 Vienna

Tel.: +43-1-40170-4080

Fax: +43-1-40170-64080

Contact: Prof. Dr. Thomas Felzmann (CEO)

Founded: 2003

Staff: 6


Sector of activities: R&D, production www.activartis.com

B M R

ad rem team GmbH – therapie4youAuenbruggergasse 2/11

1030 Vienna

Tel.: +43-1-7103165

Fax: +43-1-7104065

Founded: 1999

Staff: 6


[email protected]

M RB

Aedos Management & Beratungs Ges.m.b.HSandleitengasse 17/20/Top 3

1160 Vienna

Tel.: +43-1-87600-5152

Fax: +43-1-87600-53

Contact: Ing. Mag. Michael Pieler (Managing Director)

www.aedos.at

M RB

AFFiRiS AGKarl-Farkas-Gasse 22

1030 Vienna

Tel.: +43-1-7981575-300

Fax: +43-1-7981575-311

Contact: Dr. Walter Schmidt (CEO)

Founded: 2003

Staff: 80


Sector of activities: R&D, [email protected]

B M R



AAgfa HealthCare Ges.m.b.H.Diefenbachgasse 35

1150 Vienna

Tel.: +43-1-89966-600

Fax: +43-1-89966-110

Contact: Albrecht Müller

Founded: 1989/2005/2007

Working fields: software for medicine, telemedicine and eHealth

www.agfahealthcare.com

B RM

Agneter PharmaConsulting GmbHMariahilfer Strasse 71 / 15

1060 Vienna

Tel.: +43-1-52642-44

Contact: Dr. Ernst Agneter (Managing Director)

www.pharmaconsulting.at

M RB

Akron Molecules GmbHCampus Vienna Biocenter 5

1030 Vienna

Tel.: +43-1-7987882-200

Fax: +43-1-7987882-222

Founded: 2010


Sector of activities: R&D

[email protected]

B M R

Alcon Ophthalmika GmbHMariahilferstrasse 120

1070 Vienna

Tel.: +43-1-5966-9070

Fax: +43-1-5966-970-11


www.alcon.com

M RB



AAlgOss Biotechnologies GmbHSchumanngasse 15

1180 Vienna

Tel.: +43-1-40758-20

Fax: +43-1-40758-2010

Contact: Dr. Rolf Ewers

Founded: 2002

Staff: 3


Sector of activities: R&[email protected]

B M R

Allergopharma Vertriebsges. mbHSiebenhirtenstrasse 30

1230 Vienna

Tel.: +43-1-61571-540

Fax: +43-1-61571-53

Founded: 1969


[email protected]

M RB

Alvetra u. Werfft GmbHBoltzmanngasse 11

1090 Vienna

Tel.: +43-1-3191456-331

Fax: +43-1-3191456-344

Contact: Herbert Frantsits

Founded: 1948

Working fields: animal health

[email protected]

b M R

AME International GmbHHoyosgasse 5

1040 Vienna

Tel.: +43-1-50359-79

Fax: +43-1-50359-7920

Contact: Mag. Heinz Messinger (Manging Director)

Founded: 1995

Staff: 18

Working fields: hospital hardware, medical software, telemedicine and eHealth

Sector of activities: services, [email protected]

B RM



AAmgen GmbHPrinz-Eugen-Strasse 8-10

1040 Vienna

Tel.: +43-1-502-17

Fax: +43-1-50217-20

Founded: 1995

Staff: 100


Sector of activities: sales [email protected]

M RB

An der Grub Bio Research GmbHOrtliebgasse 25/1

1170 Vienna

Tel.: +43-1-489-42-14-0

Fax: +43-1-489-42-14-50

Founded: 1987

Working fields: non-specific services

Sector of activities: production, sales

[email protected]

B M R

AOP Orphan Pharmaceuticals AGWilhelminenstrasse 91

1160 Vienna

Tel.: +43-503-72440

Fax: +43-503-72445

Contact: Dr. Rudolf Widmann (CEO)

Founded: 1996

Staff: 50



b M R

Apeiron Biologics AGCampus-Vienna-Biocenter 5

1030 Vienna

Tel.: +43-1-8656577-0

Fax: +43-1-8656577-800

Contact: Dr. Hans Loibner (CEO)

Founded: 2003

Staff: 21



B M R



AAPEPTICO Forschung und Entwicklung GmbHc/o mingo bueros

Mariahilferstrasse 136, Top 1.15

1030 Vienna

Tel.: +43-664-143-2919

Fax: +43-664-147-7280

Contact: Dr. Bernhard Fischer (CEO)

Founded: 2008 | Staff: 5



B M R

Aptiv Solutions GmbHPyrkergasse 10/6

1190 Vienna

Tel.: +43-1-360700-8813

Fax: +43-1-360700-8810

Contact: Mag. Marion Neusser

Founded: 2007

Staff: 6


Sector of activities: services

marion.neusser@ aptivsolutions.comwww.aptivsolutions.com

M RB

ARAX Capital Partners GmbH Grinzingerstrasse 87

1190 Vienna

Tel.: +43-1-370-74740

Fax: +43-1-370-747422

Contact: Christian Tiringer

Founded: 2007

Staff: 8

Sector of activities: services [email protected]

M RB

Arsanis Biosciences GmbHHelmut-Qualtinger-Gasse 2

1030 Vienna

Contact: Eszter Nagy (MD, PhD)

Founded: 2010

Staff: 20



[email protected]

B M R



AArthur D. Little Austria GmbHSchottengasse 1

1010 Vienna

Tel.: +43-1-515-41-0

Contact: Mag. Stefan Höffinger (Managing Director)


[email protected]

M RB

Askin & Co. GmbHAlbert-Schweitzer-Gasse 6 | 1140 Vienna

Tel.: +43-1-97988-44 | Fax: +43-1-97988-46

Contact: K. R. Ing. Herbert Lugbauer


Working fields: electromechanical medical technology, hospital hardware,

non-active implantable technology, ophthalmic and optical technology, reusable

instruments, single use technology, diagnostic and therapeutic radiation tech-

nology, software for medicine, telemedicine and eHealth


M RB

Asprion Augenprothetik GmbHSpitalgasse 15/2/10

1090 Vienna

Tel.: +43-1-40623-71

Founded: 1925

Working fields: non-active implantable technology


[email protected]

B RM

Assign Clinical Research GmbHDonau City Strasse 6

1220 Vienna

Tel.: +43-1-4033805-26

Fax: +43-1-4033805-66

Contact: Mag. Katharina Trinks (Head of Clinical Project Management)

[email protected]

M RB



AAssista Laborelectronics GmbHDöblinger Hauptstrasse 95

1190 Vienna

Tel.: +43-1-36984-40

Founded: 1980


[email protected]

M RB

Astellas Pharma Ges.m.b.H.Linzer Strasse 221 E 2

1140 Vienna

Tel.: +43-1-877-2668-0

Fax: +43-1-877-1636

Contact: Berthold Cvach (Managing Director)

Founded: 1973

Staff: 55


Sector of activities: [email protected]

M RB

Astra Tech GmbHSchlosshoferstrasse 4/4/191210 ViennaTel.: +43-1-21461-50Founded: 1995Sector of activities: sales

[email protected]

M RB

AstraZeneca Österreich GmbHSchwarzenbergplatz 7

1037 Vienna

Tel.: +43-1-71131-0

Fax: +43-1-71131-221

Contact: Dr. Christian Dreger

Founded: 1963


[email protected]

M RB



AAstrid Bioscience GmbHWähringerstraße 61/2/7

1090 Vienna

Tel.: +43-1-229-7382

Fax: +43-1-229-7329

Contact: Zoltan Kovacs

Working fields: bioinformatics

[email protected]

B M R

Astro-Pharma GmbHAllerheiligenplatz 4

1200 Vienna

Tel.: +43-1-9619313

Fax: +43-1-9619314

Contact: Mag. Helmut Kaisergruber (Owner)

Founded: 2003

Staff: 17



M RB

Atomed HandelsgmbHDraschestrasse 88

1230 Vienna

Tel.: +43-1-6060580

Fax: +43-1-6060580-22

Founded: 2000


[email protected]

M RB

Austria Wirtschaftsservice GmbH (aws)Ungargasse 37

1030 Vienna

Tel.: +43-1-50175-594

Fax: +43-1-50175-908

Contact: Johannes Sarx

[email protected]

M RB



AAustrian Biotech IndustryWiedner Hauptstrasse 63

1045 Vienna

Tel.: +43-5-90900-3367

Fax: +43-5-90900-280

Contact: Dr. Franz Latzko (Managing Director)

Founded: 2001

[email protected]://biotechindustry.at

M RB

Austrian Standards InstituteHeinestrasse 38

1020 Vienna

Tel.: +43-1-21300

Fax: +43-1-21300-355

Contact: Regina Slameczka


[email protected]

M RB

AustromedBossigasse 24/7

1130 Vienna

Tel.: +43-1-87770-12

Fax: +43-1-87770-20

[email protected]

M RB

Avir Green Hills Biotechnology Research and Development Trade AGForsthausgasse 11 | 1200 Vienna

Tel.: +43-1-3199-670

Fax: +43-1-3196-099

Contact: Thomas Muster (CEO, CSO)

Founded: 2002

Staff: 40



B M R



BAxon Neuroscience Forschungs- und Entwicklungs GmbHCampus Vienna Biocenter 5 / Rennweg 95b

1030 Vienna

Tel.: +43-1-7966-8980

Fax: +43-1-7966-89820

Contact: Dr. Michael Novak (CSO)




[email protected]

B M R

B.R.A.H.M.S. Austria GmbHWehlistrasse 27B

1200 Vienna

Tel.: +43-1-585-6667-0

Fax: +43-1-585-6667-9

Contact: Hermann Schmidt


[email protected]

M RB

B.R.A.H.M.S. Diagnostica GmbHSchönbrunner Strasse 45

1050 Vienna


[email protected]

M RB

B&K Bettschart&Kofler Medien- und Kommunikationsberatung GmbHPorzellangasse 35 / Top 3

1090 Vienna

Tel.: +43-1-3194378-12

Fax: +43-1-3194378-20

Contact: Mag. Gaby Reiner

[email protected]

M RB



BBalmung Medical Handel GmbHVienna Twin Tower

Wienerbergstrasse 11

1100 Vienna

Tel.: +43-1-99460-6412


[email protected]

M RB

Bard Medica S.A.Thaliastrasse 125a/1/5

1160 Vienna

Tel.: +43-1-4949-130

Fax: +43-1-4949-13030

Contact: E. Scherbaum (CS-Manager)


Working fields: non-active implantable technology, single use technology,

components based on biological materials, others

Sector of activities: production, [email protected]

M RB

BASF Österreich GmbHHandelskai 94-96

1200 Vienna

Tel.: +43-1-87890-227

Fax: +43-1-87890-120

Contact: Joachim Meyer (Managing Director)

Founded: 1951


[email protected]

M RB

BASKO HEALTHCAREOffice Park I; Top B02

1300 Vienna

Tel.: +43-1-283533-0

Fax: +43-1-283626-2

Contact: Herbert Strauß

Founded: 1986


www.basko.com

M RB



Baxter Healthcare GmbH Stella-Klein-Löw-Weg 15

1020 Vienna

Tel.: +43-1-71120-0

Fax: +43-1-71120-2451020

Founded: 1996



BM RB

M RB

M RB

M Rb

Bauerfeind GmbHDirmhirngasse 68-74

1230 Vienna

Tel.: +43-800-4430-130

Fax: +43-800-4430-131

Founded: 1984


[email protected]

Baumgartner Ewald Feinoptik GesmbHNuschinggasse 14

1230 Vienna

Tel.: +43-1-86592-01

Fax: +43-1-86592-0118

Contact: Sabine Baumgartner

Founded: 1974

Staff: 35

Sector of activities: production [email protected]

Bausch & Lomb GesmbHOffice Park I, Top B021300 ViennaSector of activities: sales

[email protected] www.bausch-lomb.at

www.baxter.at



Bertmann feinmechanische Erzeugnisse und Werkzeugbau Gesellschaft m.b.H.Sulzengasse 3

1232 Vienna

Tel.: +43-1-6884611-0

Fax: +43-1-6884613-20

Founded: 1974

Working fields: active implantable technology, electromechanical medical

technology


Beiersdorf GmbHLaxenburger Strasse 151

1100 Vienna

Tel.: +43-1-61400-370

Fax: +43-1-61400-320


Bayer Austria Ges.m.b.HHerbststrasse 6-10

1160 Vienna

Tel.: +43-1-71146-0

Founded: 1970

Staff: 143


BBaxter Innovations GmbH Industriestrasse 67

1221 Vienna

Tel.: +43-1-20100-0

Fax: +43-1-20100-510

Founded: 1960

Staff: 3.800


Sector of activities: R&D, production

www.baxter.at

b M R

www.bayer.at

www.beiersdorf.at

[email protected]

M RB

M RB

M RB



Bio-Rad Laboratories GmbHHummelgasse 88/3-6

1130 Vienna

Tel.: +43-1-877-8901

Fax: +43-1-876-5629

Contact: Eva Welleditsch

Founded: 1977

Staff: 13

Working fields: lab equipment, consumables/reagents

Sector of activities: production, services, sales

Bioaktiva Pharmaceuticals GmbHDöblinger Hauptstrasse 16

1190 Vienna

Tel.: +43-1-374-5307

Fax: +43-1-946-1816

Founded: 2000



Bio-Products & Bio-Engineering AGSchottenring 10

1010 Vienna

Tel.: +43-1-53239-90

Fax: +43-1-53239-909

Contact: Dr. Johann Eibl (Chairman)

Founded: 1996



BIMED Dr. Karner Spitalbedarfs GmbHSiebenhirtenstrasse 13

1230 Vienna

Tel.: +43-1-86984-55

Contact: Susanne Binder


B

B M R

[email protected]

[email protected]

[email protected]

Expert 2-D Support.Bio-Rad’s global technical support team provides you trusted advice you can depend on.

Ask an ExpertFrom sample preparation to spot excision, our experienced 2-D experts are ready to help you with all your 2-D questions and problems. Get direct access to our 2-D experts through our convenient Web-based form.

Our 2-D experts are:

� Highly trained technical support professionals in the proteomics field

� Experienced with many years of hands-on research and troubleshooting expertise

� Dedicated to supporting you with the utmost personalized care

� Accessible from anywhere in the world, anytime

Make Bio-Rad your trusted advisor for 2-D by visiting us on the Web at www.expressionproteomics.com/ask/

Visit us on the Web at discover.bio-rad.comCall toll free at 1-800-4BIORAD (1-800-424-6723);outside the US, contact your local sales office.

Expression Proteomics // Tools for Protein Separation and Analysis www.expressionproteomics.com

202-7331

Bio Rad

European Biotech News

11.24.05

Expert 2D Diagnosis

05-0859_Trusted2

pdfx1a

210mm x 275mm

215mm x 280mm

11.3.05

df

qcJOB #

CLIENT

PUB/PRINTER

PUB DATE

FILE NAME

FILE TYPE

LIVE

TRIM

BLEED

DATE

OPERATOR

MAC

P/U #(S)

DESCRIPTION/HEADLINE

Client # 05-0859

ORDER. # R61020177

[email protected]

M RB

M RB

M RB



BBiogen Idec Austria GmbHStella-Klein-Löw-Weg 15/3

1020 Vienna

Tel.: +43-1-484-4613

Fax: +43-1-484-461311

Founded: 1997



Biolab GmbHPelzgasse 7

1150 Vienna

Tel.: +43-1-9827-575

Fax: +43-1-9827-589

Founded: 1983

Staff: 3

Working fields:in-vitro diagnostic technology, lab equipment,

consumables/reagents


biolution GmbHKarl-Farkas-Gasse 22

1030 Vienna

Tel.: +43-1-786-9595

Fax: +43-1-786-959520

Contact: Dr. Iris Grünert (Managing Director)

Founded: 2002

Sector of activities: production, services

[email protected]

Biomarker Design Forschungs GmbHDivischgasse 4

1210 Vienna

Tel.: +43-1-29107-41

Fax: +43-1-29107-6385

Contact: Renate Berger-Mostler (Managing Director)

Founded: 2009

Staff: 8

Working fields: human health, animal health


B M R

M RB

M RB

M RB



BBiomay AGVienna Competence Center, Lazarettgasse 19

1090 Vienna

Tel.: +43-1-79662-96100

Fax: +43-1-79662-96111

Contact: Dr. Reiner Henning (CEO)

Founded: 1984

Staff: 14


Sector of activities: R&D, production, services

[email protected]

Biomechanische Forschungs-Gesellschaft m.b.H.Rechte Wienzeile 5/2

1043 Vienna

Tel.: +43-1-58664-46

Fax: +43-1-58664-4630

Contact: Kurt Peter Judmann



Biomedica Medizinprodukte GmbH & Co. KGDivischgasse 4 | 1210 Vienna

Tel.: +43-1-291-0711

Fax: +43-1-290-1429

Contact: Dr. Michaela Weblacher (Product Manager & Sales IVD),

Dr. Petra Eibensteiner (Product Manager & Sales Life Science), Mario Wunsch,

Prof. Wolfgang Woloszczuk (CEO)


Working fields: human health, lab equipment, consumables/reagents

Sector of activities: R&D, services, sales

[email protected]

Biomedizinische Forschungsgesellschaft m.b.H.Lazarettgasse 19

1090 Vienna

Tel.: +43-1-40810-91

Fax: +43-1-40810-9113

Contact: Martha Eibl (CEO)

Founded: 1998

Staff: 19


Sector of activities: R&D [email protected]

B M R

B m R

B M R

B M R



BbioMérieux Austria GmbHEduard-Kittenberger-Gasse 95b

1230 Vienna

Tel.: +43-1-8650-650

Fax: +43-1-8650-661

Founded: 1993



Biomodels AustriaUniversitäres Zentrum für Biomodelle GmbH

Veterinärplatz 1

1210 Vienna

Tel.: +43-1-25077-2801

Fax: +43-1-25077-2809

Contact: Prof. Dr. Thomas Rülicke

Founded: 2002

[email protected]

Bioplant R&DAnton-Frank-Gasse 13

1180 Vienna

Tel.: +43-1-47654-6560

Fax: +43-1-3697615

Contact: Dr. Karin Gruber (CEO), Univ. Prof. Dr. Margit Laimer (CSO)

Founded: 2009

Staff: 5

Working fields: agricultural biotechnology


Biosanol Naturprodukte GmbHMillergasse 40

1060 Vienna

Tel.: +43-1-595-1598

Fax: +43-1-595-1293

Contact: Dr. Christina Schmidbauer

Founded: 2008


Sector of activities: R&D, production [email protected]

B M R

B M R

M RB

M RB



BBioScript InternationalBennogasse 16/9a

1080 Vienna

Tel.: +43-1-990-82-33

Contact: Dr. Ruth Willmott

[email protected]

Biotechnology ConsultingLife Science Unternehmensberatung

P. O. Box 4

1097 Vienna

Tel.: +43-664-1432-919

Fax: +43-664-25330333-779

Founded: 2003

Staff: 3



Biotest Austria GmbHEinsiedlergasse 58

1053 Vienna

Tel.: +43-1-5451561-0

Fax: +43-1-5451561-45

Contact: Dr. Gerald Schrot

Founded: 1968

Staff: 15



Biotronik Vertriebs-GmbHAm Euro Platz 2, Stiege 2

1120 Vienna

Tel.: +43-1-61544-50

Fax: +43-1-61544-5010

Founded: 1979

Staff: 30

Working fields: active implantable technology


M RB

M RB

M RB

M RB



BBiozym Biotech Trading GmbHWehlistrasse 27 b

1200 Vienna

Tel.: +43-1-334-0156-0

Fax: +43-1-334-0156-88

Contact: Ingo Stefan Nagler



[email protected]

BIUTEC R&D GmbHSeeböckgasse 32b

1160 Vienna

Tel.: +43-1-4083-5800

Fax: +43-1-4083-58034

Contact: DI Dr. Helmut Effenberger

[email protected]

Boehringer Ingelheim RCV GmbH & Co.KG Biopharmaceuticals & OperationsDr. Boehringer-Gasse 5-11 | 1120 Vienna

Tel.: +49-6132-77-0

Fax: +49-6132-77-98287

Contact: Dr. Julia Knebel (Marketing Manager), Pauline Bronzel

Founded: 1948

Staff: 1.100



bio-cmo@ boehringer-ingelheim.comwww.biopharma-cmo.com

Value through Innovation

Together To The Top

In a fast moving market we develop and manufacture your

biopharmaceuticals in a time-to-clinic and time-to-market

approach.

As a one-stop shop we offer a full spectrum of services for

therapeutics derived from microbial fermentation and cell

culture – from small to large scale and from DNA to final

dosage form.

We have globally licensed facilities and an unrivalled product

track record for worldwide supply.

Use our know-how, resources and capacity to reach the top

with us as your partner.

Contact us!

www.biopharma-cmo.com

[email protected]

Boston Scientific GmbHWienerbergstrasse 11, Turm A/ 19 OG

1100 Vienna

Tel.: +43-1-60810

Contact: Christian Jajet

Staff: 44


technology, non-active implantable technology, reusable instruments, single

use technology

Sector of activities: sales www.bostonscientific.com

M RB

M RB

b M R

M RB



BS-Immun GmbH Bestandsspezifische Impfstoffe und AutovakzinenGastgebgasse 5-13

1230 Vienna

Tel.: +43-1-997-1739

Fax: +43-1-236969-89

Contact: Dr. Astrid Weiss (Managing Director)




Bruker Austria GmbHLemböckgasse 47b / Top 10

1230 Vienna

Tel.: +43-1-80478-81

Fax: +43-1-80478-81-99

Contact: Dieter Bertelmann


Braincon Technologies GroupGrinzinger Allee 5 | 1190 Vienna

Tel.: +43-1-61067-0 | Fax: +43-1-61067-93

Contact: Christian Schön, Davul Ljuhar (Managing Director)

Founded: 1992

Staff: 12


diagnostic and therapeutic radiation technology, software for medicine,

telemedicine and eHealth

Sector of activities: R&D, production, services, sales

B

B M R

B M R

B M R

Bracco Österreich GmbHFloridsdorfer Hauptstrasse 1

1210 Vienna

Tel.: +43-1-4893495

Fax: +43-1-489495-204

Contact: Rudolf Richter


[email protected]

[email protected]

[email protected]

[email protected]

M RB



Carl Reiner GmbHMariannengasse 17 | 1090 Vienna

Tel.: +43-1-4026251-0

Fax: +43-1-4026251-19

Contact: Peter Rossegger (Managing Director)

Founded: 1912

Staff: 30

Working fields: anesthetic and respiratory technology, electromechanical

medical technology, reusable instruments


BBSN medical Medizinprodukte GmbHLaxenburger Strasse 151

1100 Vienna

Tel.: +43-1-61400-666

Fax: +43-1-61400-480

Founded: 2001


[email protected]

BSTÄNDIG VERBANDSTOFFABRIK GmbHBrünner Strasse 19

1210 Vienna

Tel.: +43-1-271-2172

Founded: 1912


[email protected]

B M R

CareTec GmbHStubenbastei 1

1010 Vienna

Tel.: +43-1-5138081-0

Fax: +43-1-5138081-9

Contact: Dr. Dietmar H. Litschel

Sector of activities: R&D, production, sales

[email protected]

[email protected]

Medizintechnik für Diagnose und TherapieManufaktur chirurgischer Instrumente

M RB

M RB

M RB



CCarl Zeiss GmbHLaxenburger Strasse 2 | 1100 Vienna

Tel.: +43-1-79518-911 | Fax: +43-1-79518-900

Founded: 1902

Staff: 83

Working fields: dental technology, electromechanical medical technology,

non-active implantable technology, ophthalmic and optical technology,

reusable instruments, single use technology, diagnostic and therapeutic

radiation technology, software for medicine, telemedicine and eHealth


CAS® Clean-Air-Service AGEURO PLAZA / Am Euro Platz 2

1120 Vienna

Tel.: +43-1-71728-285

Fax: +43-1-71728-283

Contact: DI Holger Messner


[email protected]

CBC Capricorn Biotech Consulting e.U.Untere Weissgerberstrasse 49/19

1030 Vienna

Tel.: +43-1-91306-31

Contact: Martin Götting (General Manager, Consultant)

Founded: 2009


[email protected]

CECOG – Central European Cooperative Oncology GroupSchlagergasse 6/6

1090 Vienna

Tel.: +43-1-409-77-25-11

Fax: +43-1-409-77-26

Contact: Dagmar Just

Founded: 1999

Staff: 8

Working fields: human [email protected]

B m R

M RB

M RB

M RB



CCenter for Anti-Infective AgentsEckpergasse 13

1180 Vienna

Tel.: +43-1-479 70 24

Fax: +43-1-470 08 98

Contact: Dr. Ursula Theuretzbacher (Managing Director)



Centogene GmbHCampus Vienna Biocenter 5

1030 Vienna

Tel.: +43-1-7985006-300

Fax: +43-1-7985006-804



[email protected]

CESAR Central European Society for Anticancer Drug ResearchHanglüssgasse 4/1-3

1150 Vienna

Tel.: +43-1-5223093-10

Fax: +43-1-5223093-14

Contact: Mag. Lucia Blahova




Chemgineering Planung GmbHPerfektastrasse 45

1230 Vienna

Tel.: +43-1-2557413-0

Contact: Dr. Michael Bodenteich

www.chemgineering.com

M RB

M RB

M RB

M RB



CChemomedica Medizintechnik und Arzneimittel Vetriebsges.m.b.H.Wipplinger Strasse 19 | 1013 Vienna

Tel.: +43-1-53326-6618 | Fax: +43-1-5324-705

Contact: Mag. Alexander Hayn (Managing Director)


Working fields: anesthetic and respiratory technology, dental technology,

electromechanical medical technology, hospital hardware,

single use technology, others


[email protected]

CLIMEDMedizinische Produkte

Schlachthausgasse 50/14

1030 Vienna

Tel.: +43-1-71225-41

Contact: Werner Supperer

Founded: 1996

Working fields: reusable instruments


Clinical Investigation Support Pharmaforschung GmbHKaiserstrasse 43 / Top 4

1070 Vienna

Tel.: +43-1-52340-15

Fax: +43-1-52340-15-99

Contact: Dr. Gerhard Nahler

Founded: 1990

Staff: 3


CMS Reich-Rohrwig Hainz Rechtsanwälte GmbHEbendorferstrasse 3

1010 Vienna

Tel.: +43-1-40443-2450

Fax: +43-1-40443-92450

Contact: Dr. Johannes Juranek

Founded: 1970

Staff: 176

Sector of activities: services www.cms-rrh.com

CMS_LawTax_CMYK_from101.eps

M RB

M RB

M RB

M RB



CoaChrom Diagnostica GmbH Stolzenthalergasse 6

1080 Vienna

Tel.: +43-1-699-9797

Fax: +43-1-699-1897

Contact: Bernhard Kolmer (Managing Director)

Founded: 1994

Staff: 8

Working fields: human health, non-specific services

Sector of activities: R&D, services

Cb M R

[email protected]

CogVis software und consulting gmbhPulverturmgasse 3/1a | 1090 Vienna

Tel.: +43-1-9971594-20

Fax: +43-1-9971594-91

Contact: PD Dr. Martin Kampel (Director)

Founded: 2007

Staff: 6

Working fields: electromechanical medical technology, technical aids for

disabled, software for medicine, telemedicine and eHealth

Sector of activities: R&D, production, services, [email protected]

Coloplast Ges.m.b.HThomas-Klestil-Platz 10

1030 Vienna

Tel.: +43-1-7075751-0

Fax: +43-1-707575140

Founded: 1993


[email protected]

Confidence DNA Analysen GmbHHutweidengasse 22/1

1190 Vienna

Tel.: +43-1-368-4554

Fax: +43-1-367-9664

Contact: Susanne Haas

Founded: 2003

Staff: 3


M RB

M RB

M RB



CConvaTec (Austria) GmbHSchubertring 6

1010 Vienna

Tel.: +43-1-51284-84

Fax: +43-1-51284-94

Staff: 7

Working fields: single use technology


Cook Österreich GmbHNeustiftgasse 5/1/9

1070 Vienna

Tel.: +43-1-97567-121

Fax: +43-1-97567-126

Founded: 2007


[email protected]

Crosstec Handels-GmbHRotenlöwengasse 19

1090 Vienna

Tel.: +43-1-31031-000

Fax: +43-1-31031-020

Contact: Rudolf Sindelar (Managing Director)


Working fields: non-active implantable technology, reusable instruments,

single use technology, components based on biological materials


[email protected]://crosstec.eu

CRYPTAS it-security GmbHFranzosengraben 8/4.OG

1030 Vienna

Tel.: +43-798-96960

Fax: +43-798-969698

Founded: 2003


Sector of activities: R&D, services, [email protected]

M RB

M RB

M RB

B m R



CCSL Behring GmbHAltmannsdorferstrasse 104

1120 Vienna

Tel.: +43-1-80101-2480

Fax: +43-1-80101-2810

Contact: Norbert Piana (Managing Director)

Founded: 1977

Staff: 16



[email protected]

D.A.T.A. GmbHInvalidenstrasse 5-7

1030 Vienna

Tel.: +43-660-1214-458

Fax: +43-1-710-3631

Contact: Tina Albert

Founded: 1997


Sector of activities: production, services [email protected]

Dahlhausen GmbHGroßmarktstrasse 18

1230 Vienna

Tel.: +43-1-6675-454

Fax: +43-1-6675-457

Contact: Ulrich Dahlhausen (Managing Director)

Founded: 1984

Staff: 7

Working fields: anesthetic and respiratory technology, single use technology

Sector of activities: sales www.dahlhausen.at

DAIICHI SANKYO AUSTRIA GmbHEffingergasse 21

1160 Vienna


[email protected]

M RB

B M R

M RB

M RB



Delegate Healthcare Solutions GmbHHintzerstrasse 5/2

1030 Vienna

Tel.: +43-1-7106822

Fax: +43-1-7106822-15

Contact: Dr. Hans-Dieter Räbel

Founded: 2007

DDako Österreich GmbH Pathology ProductsHietzinger Hauptstrasse 50/7

1132 Vienna

Tel.: +43-1-408-4334 | Fax: +43-1-408-4336

Contact: Rosemarie Havranek (Managing Director)

Founded: 2002

Staff: 5 | Working fields: electromechanical medical technology, in-vitro

diagnostic technology, software for medicine, telemedicine and eHealth


[email protected]

[email protected]

Deloitte Consulting GmbH Renngasse 1/ FreyungPostfach 181013 ViennaTel.: +43-1-53700-4860 Fax: +43-1-53700-1000

www.deloitte.com

Derma Medical Systems Handels- und EntwicklungsgmbHWiedner Hauptstrasse 140

1050 Vienna

Tel.: +43-1-31869-90 | Fax: +43-1-31869-909

Contact: Thomas Wenkart (MD, CEO)


Working fields: electromechanical medical technology, software for medicine,



derma@ dermamedicalsystems.comwww.dermamedicalsystems.com

B M R

B M R

M RB

M RB



DokusysElektronische Dokumentations- & Datenverarbeitungssysteme GmbH

Rußbergstrasse 54

1210 Vienna

Tel.: +43-57-555-0

Fax: +43-57-555-9000

Contact: Bernhard Riedinger

Founded: 2007


Dionex - A Part of Thermo Fisher ScientificLaxenburger Strasse 220

1230 Vienna

Tel.: +43-1-616-5125

Fax: +43-1-616-5125-55

Contact: Klaudia Tlachac

Working fields: lab equipment


D

B M R

Dermapharm GmbHTürkenstrasse 25/12

1090 Vienna

Tel.: +43-1-3193001-0

Fax: +43-1-3193001-40

Contact: Martin Schröckenfuchs (Managing Director)

Founded: 2001


dialog gentechnikKarl-Farkas-Gasse 22

1030 Vienna

Tel.: +43-1-90-72677

Fax: +43-1-90-72606

Contact: Brigitte Gschmeidler

Staff: 12

[email protected]

[email protected]/dionex

[email protected]

M RB

M RB

M RB



DDonauchem GmbHLisztstrasse 4

1030 Vienna

Tel.: +43-1-71148-0

Fax: +43-1-71148-5

Contact: Dr. Alain de Krassny

Founded: 1973

Working fields: consumables/reagents


www.donauchem.at

Dräger Medical Austria GmbHPerfektastrasse 67

1230 Vienna

Tel.: +43-1-6093-602

Fax: +43-1-6996-242


[email protected]

A. Duschek GmbHLaxenburger Strasse 218

1230 Vienna

Tel.: +43-1-888-3112

Fax: +43-1-888-3112-40



medical technology, non-active implantable technology, single use technology,

components based on biological materials


Dutalys GmbHMuthgasse 11/2

1190 Vienna

Tel.: +43-1-99718-32

Fax: +43-1-99718-3201

Contact: Dr. Roland Beckmann (CSO)

Founded: 2008

Staff: 4



[email protected]

M RB

M RB

M RB

B M R



Ddwh simulation servicesNeustiftgasse 57-59

1070 Vienna

Tel.: +43-1-5860-180

Fax: +43-1-5860-1801

Contact: Niki Popper


www.drahtwarenhandlung.at

e|n|w|c Natlacen Walderdorff Cancola Rechtsanwälte GmbHSchwarzenbergplatz 7

1030 Vienna

Tel.: +43-1-71655-0

Fax: +43-1-71655-99

Contact: Nicole Reiter

[email protected]

eBioscienceCampus Vienna Biocenter 2

1030 Vienna

Tel.: +43-1-79640-40-0

Fax: +43-1-79640-40-400

Contact: Dr. Irene Rech-Weichselbraun

Founded: 1998

Staff: 55

Working fields: non-specific services, consumables/reagents


[email protected]

Ecolab GmbHErdbergstrasse 29

1030 Vienna

Tel.: +43-1-7152-550

Fax: +43-1-7152-550-2850

www.at.ecolab.eu

M RB

M RB

b M R

M RB



Eli Lilly GmbH Kölblgasse 8-10

1030 Vienna

Tel.: +43-1-71178-0

Fax: +43-1-71178-206

Contact: Peter Salzmann

Founded: 1976

Staff: 180

E

b M R

Edwards Lifesciences Austria GmbHAnton-Baumgartner-Strasse 125|6|1

1230 Vienna

Tel.: +43-1-20220-0

Fax: +43-1-24220-150

Contact: Anna van Maldegem

Founded: 2000

Staff: 16

Working fields: non-active implantable technology, single use technology


Ekomed Handels-Ges.m.b.HFranz-Heider-Gasse 7

1230 Vienna

Tel.: +43-1-8692771

Fax: +43-1-8692771-17

Contact: Bernhard Holzheu (Managing Director)

Founded: 1993

Staff: 4

Working fields: in-vitro diagnostic technology, single use technology

Sector of activities: production, services, sales [email protected]

[email protected]

EMCOOLS Medical Cooling Systems AGBrucknerstrasse 6/7a

1040 Vienna

Tel.: +43-2252-890-152-0

Fax: +43-2252-890-152-119

Contact: Michael Kühling (CEO)




M RB

M RB

B M R



Eemergentec biodevelopment GmbHGersthofer Strasse 29-31

1180 Vienna

Tel.: +43-1-4034-966-0

Fax: +43-1-4034-966-19

Contact: Arno Lukas (CEO), Dr. Bernd Mayer (CSO)

Founded: 2002

Staff: 12

Working fields: bioinformatics


en.co.tec Schmid KGBreitenfurter Strasse 401-413/25/R1

1230 Vienna

Tel.: +43-1-8863-491

Fax: +43-1-8863-491-18

Founded: 1999

Staff: 4

[email protected]

[email protected]

Endo Unique Handelsgesellschaft m.b.HNeumayrgasse 21

1160 Vienna

Tel.: +43-1-49527-99

Contact: Gerald Fritsch


www.endounique.at

Engler Steritech GmbHRotenmühlgasse 61/1

1120 Vienna

Tel.: +43-1-607-4169

Fax: +43-1-607-4669

Contact: Georg Engler (Managing Director)

[email protected]

B M R

M RB

M RB

M RB



EEppendorf Austria GmbHIgnaz-Köck-Strasse 10

1210 Vienna

Tel.: +43-1-8901364-41

Fax: +43-1-8901364-20

Contact: Dipl.-Ing. Mathias Wenisch (Managing Director)



[email protected]

EQ-SERVE EDV & Labortechnik GmbHBürgergasse 11

1100 Vienna

Tel.: +43-1-796-8526

Fax: +43-1-796-8526-22

[email protected]://eq-serve.com

Erbe Elektromedizin Ges.mbHModecenterstrasse 14 TOP B1

1030 Vienna

Tel.: +43-1-8932-446

Fax: +43-1-8932-4463

Contact: Christian Böhm

Founded: 1968

[email protected]

Ernst Stöhr GmbHMauerbachstrasse 4

1140 Vienna

Tel.: +43-1-9791211

Fax: +43-1-9792153

Contact: Ernst Stöhr


[email protected]

M RB

M RB

M RB

B M R



EEubioSchwendergasse 17

1150 Vienna

Tel.: +43-1-8950-145

Fax: +43-1-8950-14514

[email protected]

EUCODIS Bioscience GmbHCampus Vienna Biocenter II

Viehmarktgasse 2 a/ 2. OG | 1030 Vienna

Tel.: +43-1-8900-804

Fax: +43-1-8900-804 ext. 11

Contact: Thomas Fischer (CEO)

Founded: 2007

Staff: 21

Working fields: industrial processing

Sector of activities: production, services, [email protected]

EuromedMedizinisch Technische ProdukthandelsgmbH

Nobilegasse 23-25

1150 Vienna

Tel.: +43-1-9793850

Fax: +43-1-9793850-20


[email protected]

Evercyte GmbHMuthgasse 18

1190 Vienna

Tel.: +43-664-4227-861

Contact: Otto Kanzler (CEO)

Founded: 2011

Staff: 4


Sector of activities: R&D, services [email protected]

M RB

B M R

M RB

B M R



FExperGen Drug Development GmbHHernalser Hauptstrasse 24

1170 Vienna

Tel.: +43-1-40597-86

Contact: Dr. Paul Meng

Founded: 2006


[email protected]

F-starBiotechnologische Forschungs- und Entwicklungs-GmbH

Gastgebgasse 5-13

1230 Vienna

Tel.: +43-72055-4215

Fax: +43-1-8655-550

Contact: Dr. Kevin FitzGerald (CEO)




Felcon Reinraum- und Prozesstechnische Anlagen Produktionsgesellschaft m.b.H.Kerngasse 38

1236 Vienna

Tel.: +43-1-8885545-0

Fax: +43-1-8885545-23

Contact: Ing. Hans Lintner (Managing Director)

[email protected]

FEMTOLASERS Produktions GmbHFernkorngasse 10

1100 Vienna

Tel.: +43-1-503-7002-0

Fax: +43-1-503-7002-99

Contact: Andreas Stingl (CEO)


Working fields: electromechanical medical technology, ophthalmic and optical

technology


B M R

B M R

M RB

M RB



FFerdinand Menzl Medizintechnik GmbHDonaufelderstrasse 199

1220 Vienna

Tel.: +43-1-25589-600

Fax: +43-1-25589-6060

Contact: Manfred Menzl (Managing Director)

Founded: 1976

Staff: 8

Working fields: single use technology, others

Sector of activities: services, [email protected] www.menzl.com

Fisher & Paykel Healthcare GmbH & Co KGWagramer Strasse 19

1220 Vienna

Tel.: +43-800-293-123

Fax: +43-800-293-122


[email protected]

Fonds zur Förderung der wissenschaftlichen Forschung (FWF)Sensengasse 1

1090 Vienna

Tel.: +43-1505-6740-0

Fax: +43-1505-6739

Founded: 1968

Staff: 90


FOSS GmbHEitnergasse 7

1230 Vienna

Tel.: +43-1-2781-631

Fax: +43-1-2781-631-15


[email protected]

M RB

M RB

M RB

M RB



Franz Kacer & Sohn GmbHFrankgasse 3

1090 Vienna

Tel.: +43-1-4052-567

Contact: Thomas Krach

Founded: 1972

Working fields: technical aids for disabled

Sector of activities: production

FB M R

[email protected]

Fresenius Medical Care Austria GmbHLundenburgergasse 5

1210 Vienna

Tel.: +43-1-29235-01

Founded: 1976

Staff: 27



[email protected]

Dr. Friedrich Bertoni Gesellschaft mbHJochen-Rindt-Strasse 211230 ViennaTel.: +43-1-61688-70Fax: +43-1-61688-7060Founded: 1974Working fields: consumables/reagentsSector of activities: sales

[email protected]

Fuji Film Österreich Gesellschaft m.b.H. Nfg. KGTraviatagasse Ecke Pfarrgasse | 1230 Vienna

Tel.: +43-1-6162-6060 | Fax: +43-1-61626-06/58

Contact: Thomas Scheibenbauer (Marketing/Sales)


Working fields: electromechanical medical technology, in-vitro diagnostic

technology, reusable instruments, single use technology, software for

medicine, telemedicine and eHealth


M RB

M RB

M RB



gcp gamma capital partners AGSchönbrunner Strasse 218-220 Stiege A / Top 4.041120 ViennaTel.: +43-1-51310-72Fax: +43-1-51310-72200Contact: Burkhard Feurstein (Managing Partner), Dr. Oliver Grabherr, Hannes Ambacher (Cofounder)Founded: 2002Sector of activities: services

G

[email protected]

GE Healthcare Austria GmbH & Co OGTechnologiestrasse 101120 ViennaTel.: +43-1-97272-2607Fax: +43-1-97272-2222Sector of activities: sales

GENOSENSE Diagnostics GmbHDonau-City-Strasse 1

1220 Vienna

Tel.: +43-1-2530-253-190

Fax: +43-1-2530-253-191

Contact: Prof. Dr. Manfred Müller

Founded: 2001

Staff: 10



Genzyme Austria GmbHFranz-Klein-Gasse 5

1190 Vienna

Tel.: +43-1-77465-38

Fax: +43-1-77465-389


M RB

M RB

www.ge-healthcare.com

www.genzyme.com

M RB

B M R



GGepa-Med Medizintechnik GmbHSprengersteig 4

1160 Vienna

Tel.: +43-1-489-6353

Fax: +43-1-489-635343

Contact: Gerhard Pavecic


[email protected]

Gesellschaft Österreichischer ChemikerNibelungengasse 11/6

1010 Vienna

Tel.: +43-1-587-4249

Fax: +43-1-587-8966

Contact: Dr. Erich Leitner, Gabriela Ebner

Founded: 1897

Staff: 1900

[email protected]

GHX Austria GmbHSimmeringer Hauptstrasse 24

1110 Vienna

Tel.: +43-1-74040-5711

[email protected]

GJM Handel und Service GmbHLange Gasse 58

1080 Vienna

Tel.: +43-1-40808-41

Fax: +43-1-40808-43

Contact: Gerd R. Melmuka (Executive Vice President)



reusable instruments, single use technology


[email protected]

M RB

M RB

M RB

M RB



GGlaxoSmithKline Pharma GmbHAlbert-Schweitzer-Gasse 6

1140 Vienna

Tel.: +43-1-97075-0

Fax: +43-1-97075-170

Contact: DI Alexander Barta (Director Business Development)


[email protected]

Globopharm GmbH Breitenfurter Strasse 251

1230 Vienna

Tel.: +43-1-8031727

Fax: +43-1-8031727-372

Contact: Dr. Kurt Burghart

Founded: 1994



GN ReSound Hörtechnologie GmbHWimbergergasse 14-16

1070 Vienna

Tel.: +43-1-5245400-400

Fax: +43-1-5245400-444

Contact: Norbert Gabriel


www.gnresound.at

Grabner Instruments Messtechnik Gesellschaft m.b.HDr.-Otto-Neurath-Gasse 1

1220 Vienna

Tel.: +43-1-2821-6270

Fax: +43-1-2807-334

Founded: 1987

[email protected]

M RB

M RB

M RB

b M R



Haplogen GmbHKaiserstrasse 32

1070 Vienna

Tel.: +43-1-40160-70026

Contact: Dr. Georg Casari (CEO)

Founded: 2010

Haemonetics Handelsgesellschaft mbHMariahilferstrasse 123/3.Stock

1060 Vienna

Tel.: +43-1-294-2900


H

B M R

Dr. Grossegger & Drbal GmbHRuthgasse 19/1

1190 Vienna

Tel.: +43-1-368-17-97

Fax: +43-1-367-70-23

Founded: 1980

Staff: 5

Working fields: others

Sector of activities: production [email protected]

Habel MedizintechnikIgnaz-Köck-Strasse 20

1211 Vienna

Tel.: +43-1-29266-420

Fax: +43-1-29012-45

Founded: 1952



[email protected]

[email protected]

[email protected]

M RB

B M R

M RB



HHarrison Clinical Research Eastern Europe Forschungsges.mbHKärntner Ring 10/Top 12a

1010 Vienna

Tel.: +43-1-5046591-0

Fax: +43-1-5046591-44

Founded: 2004

Staff: 6



[email protected]

Hauser M. MedizintechnikMaurer-Lange-Gasse 136

1230 Vienna

Tel.: +43-1-8654-477

Fax: +43-1-8654-4779

Founded: 1997


[email protected]

HEILAND Medical Vertriebs-GmbHComputerstrasse 6

1100 Vienna

Tel.: +43-1-718-1961


[email protected]

Heilbehelfe FrühwaldDipl. Ing. Frühwald & Söhne

Börseplatz 7

1010 Vienna

Tel.: +43-1-5332100

Contact: Ing. Karl Frühwald

Founded: 1969


M RB

M RB

M RB

M RB



R.Heintel GmbHJosefstädterstrasse 82 | 1081 Vienna

Tel.: +43-1-40389-56 | Fax: +43-1-40389-5650

Contact: Markus Pöltenstein (Managing Director)


Working fields: anesthetic and respiratory technology, dental technology,

electromechanical medical technology, hospital hardware, non-active implantable

technology, ophthalmic and optical technology, reusable instruments, single use

technology, technical aids for disabled


HHeinen + Löwenstein GmbHClemens-Holzmeister-Strasse 4

1100 Vienna

Tel.: +43-1-615-1134

Fax: +43-1-25330-339793

[email protected]

[email protected]

Heraeus Kulzer Austria GmbHNordbahnstrasse 36/2/4/Top 4.5

1020 Vienna

Tel.: +43-1-4080-9410

Fax: +43-1-4080-94171

Contact: Alexandra Lacek-Cipone (Managing Director)

Founded: 1971

Staff: 22

Working fields: dental technology, single use technology


Hermes Pharma Ges.m.b.H.Landstrasser Hauptstrasse 2a

1030 Vienna

Tel.: +43-1-22711-0

Fax: +43-1-22711-3150

Contact: Holger Dietel

Founded: 2003

www.hermes-pharma.at

M RB

B M R

B m R

B M R



HHitachi Medical Systems GmbHJakschgasse 5

1140 Vienna

Tel.: +43-1-8959-525

Fax: +43-1-8959-52525

Working fields: electromechanical medical technology,

diagnostic and therapeutic radiation technology

Sector of activities: sales austria@ hitachi-medical-systems.comwww.hitachi-medical-systems.at

HO-MED HandelsgmbHFlorian-Berndl-Gasse 43

1220 Vienna

Tel.: +43-1-715-9119

Fax: +43-1-71591-1919


[email protected]/

HOLLISTER GmbHHeinrich-Collin-Strasse 1

1140 Vienna

Tel.: +43-1-877-0800

Fax: +43-1-87708-0022

Contact: Mag. Stephan E. Bonnelycke

Founded: 1999

Staff: 10

Working fields: technical aids for disabled


hollister.oesterreich@ hollister.comwww.hollister.com

Hospitec WarenhandelsgmbHSchlachthausgasse 29

1030 Vienna

Tel.: +43-1-7982-2410

Fax: +43-1-7982-24111

Staff: 6

Working fields: non-active implantable technology, ophthalmic and optical

technology, reusable instruments, single use technology, components based

on biological materials, others


[email protected]

B M R

B M R

B M R

B M R



IHVD Life Science Vertriebs GmbHWurzbachgasse 18

1150 Vienna

Tel.: +43-1-982-9526

Fax: +43-1-78636-44

Contact: Werner Bürgler (Sales Director)

Founded: 1998

Staff: 7

Working fields: in-vitro diagnostic technology, consumables/reagents


[email protected]

Hygienic Technology, GMP Services & TestingBreitenfurter Strasse 111

1120 Vienna

Tel.: +43-1-804-80280

Fax: +43-1-804-802880

[email protected]

ICC – Internationale Gesellschaft für Getreidewissenschaft und -technologieMarxergasse 2

1030 Vienna

Tel.: +43-1-70772-020

Fax: +43-1-70772-040

Contact: Dr. Roland Poms

Founded: 1955

Staff: 6


IMCL – Institut für medizinische und chemische Labordiagnostik Gesellschaft mbHRosensteingasse 49 – 51

1170 Vienna

Tel.: +43-1-485-6161

Fax: +43-1-485-6161200

www.imcl.at

B M R

B M R

B M R

B M R



Iimpactit GmbHVienna Twin Tower

Wienerbergstrasse 11/12a

1100 Vienna

Tel.: +43-1-9946-06207

Fax: +43-1-9946-05307

[email protected]

In Vitro – Labor für veterinärmedizinische Diagnostik und HygieneRennweg 95

1030 Vienna

Tel.: +49-1-79962-290

Contact: Dr. Ernst Leidinger

www.invitro.at

ingenetix GmbHSimmeringer Hauptstrasse 24

1110 Vienna

Tel.: +43-1-74040-391

Fax: +43-1-74040-392

Contact: DI Dr. Irina Korschineck

Founded: 2003

Staff: 7

Working fields: non-specific services, consumables/reagents


[email protected]

INiTS Universitäres Gründerservice Wien GmbHGraumanngasse 7

1150 Vienna

Tel.: +43-1-7157-267

Fax: +43-1-7157-267-25

Founded: 2002


[email protected]

B M R

B M R

B M R

B M R



IInnovation Coaches Stadler KGFavoritenstrasse 16

1040 Vienna

Tel.: +43-680-20688-53

Fax: +43-125-33033-8417

Contact: Mag. Manfred Stadler (MBA)


Working fields: human health, natural resource recovery, environment,

industrial processing, bioinformatics


[email protected]

Institut für medizinische und chemische Labordiagnostik Gesellschaft m.b.H.Rosensteingasse 49-51

1170 Vienna

Tel.: +43-1-485-6161

Founded: 1987

www.imcl.at

Intercell AGCampus Vienna Biocenter 3

1030 Vienna

Tel.: +43-1-20620

Fax: +43-1-20620-800

Contact: Mag. Nina Waibel (Global Head Corporate Communications)

Founded: 1997

Staff: 193



Interpharm ProduktionsgmbHEffingergasse 21

1160 Vienna

Tel.: +43-5-997730-380

Fax: +43-5-997730-390

Contact: Martina Steinle

Founded: 1969

[email protected]

B M R

B M R

B M R

B M R



Intervet Ges.mbH Siemensgasse 107

1210 Vienna

Tel.: +43-1-2568-787-400

Fax: +43-1-2568-787-419

Contact: Dr. Jürgen Böckmann

Founded: 1997



I

www.intervet.at

INTRAMED Handels Ges.m.b.H.Hügelgasse 10

1130 Vienna

Tel.: +43-1-876-0101

Fax: +43-1-876-010166


[email protected]

Inventogen GmbH Ingenieurbüro für MolekularbiologieEinsiedlergasse 36/2

1050 Vienna

Tel.: +43-1-5480-415

Fax: +43-664-7313-5610

Contact: Mag. Ferdinand Kaser


Working fields: human health, bioinformatics


IPO Beteiligungs-Management AGArgentinierstrasse 42

1040 Vienna

Tel.: +43-1-505-6320

Fax: +43-1-505-632050

[email protected]

b M R

B M R

B M R

B M RB M R



JEDER GmbHStarkfriedgasse 62

1190 Vienna

Tel.: +43-1-4700-165

Fax: +43-810-955411-8233

Contact: Mag. Andreas Bayerle (Managing Director)

Founded: 2010

Working fields: dental technology


J

B M R

J&P MEDICAL RESEARCH Ltd.Auhofstrasse 15/8-91130 ViennaTel.: +43-1-8760-432-10 Fax: +43-1-8760-432-33Contact: Prof. MD Christian Joukhadar (Managing Director & Chief Operating Officer)Founded: 2007 | Staff: 22Working fields: human healthSector of activities: R&D, services

[email protected]

Janssen-Cilag Pharma GmbHVorgartenstrasse 206b

1020 Vienna

Tel.: +43-1-610-300

Fax: +43-1-616-1241

Contact: Dr. Carine Brouillon


[email protected]

Johnson & Johnson Medical Products GmbHVorgartenstrasse 206B

1020 Vienna

Tel.: +43-1-360-25

Fax: +43-1-360-25-502


[email protected]

B M R

B M R

B M R

www.janssen.at



JJoseph Babicky GmbHGoldeggasse 21040 ViennaTel.: +43-1-50582-690Working fields: reusable instrumentsSector of activities: production

[email protected]

Jungbunzlauer Austria AGSchwarzenbergplatz 16

1011 Vienna

Tel.: +43-1-50200-0

Fax: +43-1-50200-8

Contact: Dr. Gass

Staff: 300



www.jungbunzlauer.com

K.I.S Krankenhaus Informations Systeme GmbHLeonard-Bernstein-Strasse 10

1220 Vienna

Tel.: +43-1-5952-1500

Fax: +43-1-5952-15030

[email protected]

Karl Storz Endoskop Austria GmbHLandstrasse Hauptstrasse 148/1/G1

1030 Vienna

Tel.: +43-1-7156-0470

Fax: +43-1-7156-0479


[email protected]

B M R

B M R

B M R

B M R



KKaVo-AUSTRIA Dentalwarenhandel GmbHGutheil-Schoder-Gasse 7a

1100 Vienna

Tel.: +43-1-665-0133

Fax: +43-1-665-013317

Contact: Hans Bättig



reusable instruments, diagnostic and therapeutic radiation technology


[email protected]

KCI Austria GmbHLemböckgasse 49/Stiege A

1230 Vienna

Tel.: +43-1-863-30

Fax: +43-1-863-306


[email protected]

KladoMed GmbHPenzinger Strasse 61

1140 Vienna

Tel.: +43-1-577-2122

Fax: +43-1-577-2123


[email protected]

Köcher KGDöblinger Gürtel 21-23/8/9

1190 Vienna

Tel.: +43-1-597-1101


[email protected]

B M R

B M R

B M R

B M R



KKrainer Medtechnik Handelsgesellschaft mbHOber-Laaerstrasse 222

1100 Vienna

Tel.: +43-1-688-4332

Fax: +43-1-688-43323

Founded: 1979

Working fields: non-active implantable technology, single use technology,

others


Kwizda Agro GmbH Dr.-Karl-Lueger-Ring 6

1010 Vienna

Tel.: +43-5-9977-10

Fax: +43-5-9977-10280

Contact: Dkfm Dr. Johann Franz Kwizda

Founded: 1950

Working fields: agricultural [email protected]

Kwizda Pharma GmbHEffingergasse 21

1160 Vienna

Tel.: +43-5-997730-0

Fax: +43-5-997730-230

Contact: Reinhard Mahr

Founded: 1981

[email protected]

Kybermed Handelsgesellschaft mbHCottagegasse 69/13

1190 Vienna

Tel.: +43-1-328-4800

Fax: +43-1-328-4555


B M R

b M R

B M R

B M R



LLab Technologies Medizintechnik GmbHSchönbrunner Strasse 185

1120 Vienna

Tel.: +43-1-419-1027

Fax: +43-1-419-1026


[email protected]

LABDIA Labordiagnostik GmbHZimmermannplatz 8

1090 Vienna

Tel.: +43-1-40077-4800

Fax: +43-1-40077-7437

Contact: Prof. Dr. Thomas Lion (Medical Director)

Founded: 2006

Staff: 15



[email protected]

Labor 9000 Gerald Fiedler e. U.Liniengasse 9/11

1060 Vienna

Tel.: +43-1-587-4104

Fax: +43-1-587-41043

Founded: 2008


Sector of activities: [email protected] www.labor9000.at

Laboratorium für BetriebshygieneMuthgasse 18, Z6

1190 Vienna

Tel.: +43-1-47654-1250

Fax: +43-1-47654-1251

Contact: Helga Weisse

Staff: 8



B M R

B M R

B M R

B M R



LLaborchemie Gerätevertriebs GmbHKanitzgasse 21

1230 Vienna

Tel.: +43-1-888-2601

Fax: +43-1-889-2355

[email protected]

LARS Vertrieb von Implantaten GmbHMooslackengasse 17

1190 Vienna

Tel.: +43-1-8795-225

Fax: +43-1-8795-225-50

[email protected]

Laser-Gruppe-Materialbearbeitungs GesmbHMissindorfstrasse 21

1140 Vienna

Tel.: +43-1-98-55571

Fax: +43-1-98-25846

Staff: 5


[email protected]

legis.Brucknerstrasse 6

1040 Vienna

Tel.: +43-1-51365-88

Fax: +43-1-51365-8833

Contact: Dr. Manuela M. Pacher (Managing Director)

[email protected]

B M R

B M R

B M R

B M R



LIFE RESEARCH Technologies GmbHParkring 10

1010 Vienna

Tel.: +43-699-1724-9430

Fax: +43-516-33-3000

Founded: 2008



Lexogen GmbHCampus Vienna Biocenter 5

1030 Vienna

Tel.: +43-1-34512-12

Fax: +43-1-34512-1299

Contact: Alexander Seitz (CEO)

Founded: 2007

Staff: 21



L

B M R

B M R

Leica Mikrosysteme GmbHHernalser Hauptstrasse 219

1170 Vienna

Tel.: +43-1-48899-0

Fax: +43-1-48899-350

Contact: Ing. Stefan David

Founded: 1985

www.leica-microsystems.com

Leonhard Lang GmbHFeuchterslebengasse 73

1100 Vienna

Tel.: +43-1-8179-007

Fax: +43-1-8179-260


www.leonhardlang.com

[email protected]

[email protected]

B M R

B M R



LLife Science Austria – LISAUngargasse 37

1030 Vienna

Tel.: +43-1-50175-510

Fax: +43-1-50175-908

Contact: Sonja Polan

Founded: 2002

Staff: 5

Sector of activities: services [email protected] www.lifescienceaustria.at

LISAvienna – Life Science Austria ViennaUngargasse 37

1030 Vienna

Tel.: +43-1-50175-358

Fax: +43-1-50175-492

Founded: 2002

Staff: 4


[email protected]

Vienna Life Science Report Sector Survey: Facts and Directory 2011/2012

www.lisavienna.at

life-science Karriere ServicesBreitenseer Strasse 49

1140 Vienna

Tel.: +43-1-2367289-7208

Fax: +43-1-983 12 29

Contact: DI Gisela Zechner (Managing Director)

Founded: 2002


Lifescience-TexteObermüllnerstrasse 17/42

1020 Vienna

Tel.: +43-676-940-2667

Contact: Dr. Eva Müller

Founded: 2001


[email protected]

B M R

B M R

B M R

B M R



LLifeTech Austria Zweigniederlassung Applied Biosystems DivisionMahlerstrasse 13/5-7

1010 Vienna

Tel.: +43-1-86735-75

Fax: +43-1-86735-72

Contact: Mag. Andrea Janesch

Founded: 1966



Austria.order@ eur.appliedbiosystems.comwww.europe. appliedbiosystems.com

LIMBECK, Medizinische SpezialartikelGanghofergasse 22 | 1110 Vienna

Tel.: +43-1-7675521-0

Fax: +43-1-7675521-11

Contact: Richard Limbeck (Owner)

Staff: 40


medical technology, in-vitro diagnostic technology, non-active implantable

technology, reusable instruments, single use technology


Linder Helmut Ing. KGCzerningasse 18

1020 Vienna

Tel.: +43-1-2140105-0

Fax: +43-1-2162970-10


[email protected]

Lohmann & Rauscher GmbHJohann-Schorsch-Gasse 4

1141 Vienna

Tel.: +43-1-57670-0

Fax: +43-1-57717-99

Contact: DI Rudolf Leitner

Founded: 1984


B M R

B M R

B M R

B M R



MM+W Dental Handels GmbHAlbert-Schweitzer-Gasse 6

1140 Vienna

Tel.: +43-1-9794-8420

Fax: +43-1-9794-84220


[email protected]

Marinomed Biotechnologie GmbHVeterinärplatz 1

1210 Vienna

Tel.: +43-1-25077-4460

Fax: +43-1-25077-4493

Contact: Johanna Uhlmann (BD & L)

Founded: 2006

Staff: 24



Matzka Rehatechnik GmbHGentzgasse 166

1180 Vienna

Tel.: +43-1-47915-660

Fax: +43-1-447002-03

Contact: Walter Matzka

Staff: 35


MayLab Analytical Instruments GmbHPostgasse 11

1010 Vienna

Tel.: +43-1-78642-5820

Fax: +43-1-78642-5850

Contact: Hans Mayrhofer



B M R

B M R

B M R

B M R



MMCS Laborinformationssysteme GmbHParkring 10

1010 Vienna

Tel.: +43-1-51633-3111

Fax: +43-1-51633-3010

Contact: Heidelinde Raab

www.mcs-ag.com

MCW Handelsgesellschaft mbHBreuninggasse 6

1230 Vienna

Tel.: +43-1-6675-6650

Contact: Klaus Propst (Managing Director)


[email protected]

medCare Medizintechnik Vertriebs GesmbHHietzinger Hauptstrasse 93

1130 Vienna

Tel.: +43-1-60362-04

Contact: Inga Much


[email protected]

Med-Lab GesmbHWolfgang-Pauli-Gasse 5 | 1140 Vienna

Tel.: +43-1-817-9050 | Fax: +43-1-817-905015

Contact: Ing. Herbert Lugbauer (Managing Director)


Working fields: electromechanical medical technology, hospital hardware, IVD,

non-active implantable technology, ophthalmic and optical technology, single

use technology, diagnostic and therapeutic radiation technology, technical aids

for disabled, software for medicine, telemedicine and eHealth


[email protected]://med-lab.at

B M R

B M R

B M R

B M R



MMedartis GmbHWienerbergstrasse 11/12 A

1100 Vienna

Tel.: +43-1-99460-6499

Contact: Thomas Alge

Founded: 1997


www.medartis.com

Medexter Healthcare GmbHBorschkegasse 7/5

1090 Vienna

Tel.: +43-1-968-0324

Fax: +43-1-968-0922

[email protected]

Mediatum GmbHHietzinger Hauptstrasse 55a

1130 Vienna

Tel.: +43-1-87755-59

Fax: +43-1-87755-5920

Contact: Andreas Perklitsch (Managing Director)


www.mediatum.com

Medical Sales Consultants Austria GmbHPeter-Jordan-Strasse 81/2/3

1180 Vienna

Tel.: +43-1-957-9715

Fax: +43-1-957-8261

Contact: Walter Walla (Consultant)


Working fields: anesthetic and respiratory technology, hospital hardware,



[email protected]

B M R

B M R

B M R

B M R



Medifina Medizinprodukte Vertriebs-GmbHPuchsbaumplatz 5/3-4

1100 Vienna

Tel.: +43-1-2368520

Fax: +43-1-2368520-9

Contact: Dr. Johann Krocza

Founded: 2006


MB M R

[email protected]

medikusmedizintechnische und pharmazeutische Vertriebs GmbH

Diefenbachgasse 35/3/Top 5

1150 Vienna

Tel.: +43-1-9441-326

Fax: +43-1-25330-332570

Contact: Christian Kraule (Managing Director)



Sector of activities: R&D, production, [email protected]

Medmobile Medizintechnik GmbHAlszeile 103

1170 Vienna

Tel.: +43-1-228 88 75

Contact: Gerold Porenta


[email protected]

Medos Medizintechnik OGLöwengasse 3

1030 Vienna

Tel.: +43-1-715-1474

Contact: Sabine Grundner


[email protected]

B M R

B M R

B M R



MERCK GesmbH Zimbagasse 5

1140 Vienna

Tel.: +43-1-57600-0

Fax: +43-1-57733-70

Contact: Dr. Andreas Peilowich

Founded: 1998

M

b M R

MedTech-Support GmbHHirschstettner Strasse 19b

1220 Vienna

Tel.: +43-664-849-6420

Contact: Ing. Aurelius Zdrazil


[email protected]

Medtronic Österreich GmbHHandelskai 94-96 | 1200 Vienna

Tel.: +43-1-24044-0

Fax: +43-1-24044-100

Contact: Wolfgang Deutschmann



technology, non-active implantable technology, single use technology, software

for medicine, telemedicine and eHealth

Sector of activities: R&D, production, [email protected]

A. Menarini GmbHPottendorfer Strasse 25-27

1120 Vienna

Tel.: +43-1-8041-576-0

Fax: +43-1-8041-576-150

Founded: 1988

Staff: 33


[email protected]

[email protected]

B M R

B M R

B M R



Merz Pharma Austria GmbH Guglgasse 17

1110 Vienna

Tel.: +43-1-869160-40

Fax: +43-1-869160-4018



M

b M R

Merck Sharp & Dohme Ges.m.b.H.EURO PLAZA Gebäude G, 5. Stock, Am Euro Platz 2

1120 Vienna

Tel.: +43-1-12044-0

Fax: +43-1-12044-444

Contact: Mag. Paul Wachter

Founded: 1971/2004


www.msd.at

[email protected]

Metrohm INULA GmbHShuttleworthstrasse 25

1210 Vienna

Tel.: +43-1-40562-350

Fax: +43-1-40562-3599

[email protected]

Michor Consulting e.U.Schönbrunner Strasse 238/2/7

1120 Vienna

Tel.: +43-699-1952-1662

Contact: Dr. DI Salma Michor


[email protected]

B M R

B M R

B M R



MIRACOR Medical Systems GmbHGumpendorfer Strasse 139/5

1060 Vienna

Tel.: +43-1-236657-612

Fax: +43-1-236657-622

Contact: Jon Helge Hoem (CEO)

Founded: 2008

Staff: 11

Working fields: electromechanical medical technology, single use technology


M

B M R

Micros Produktions- und Handelsges.m.b.H.Breitenfurterstrasse 38

1120 Vienna

Tel.: +43-1-8027-270

Fax: +43-1-8027-271

Contact: Herbert Luttenberger

Founded: 1994

[email protected]

Millipore GesmbHHietzinger Hauptstrasse 1451130 ViennaTel.: +43-1-87789260Sector of activities: sales

www.millipore.com

[email protected]

MMS Medicor Medical Supplies GmbHWeyeringergasse 6 Top 2

1040 Vienna

Tel.: +43-1-50466-710

Contact: DI Heinz Gerhards


[email protected]

B M R

B M R

B M R



Mölnlycke Health Care GmbHWagenseilgasse 14

1120 Vienna

Tel.: +43-1-2788542

Fax: +43-1-2788542-199

Contact: Pierre Guyot

Founded: 1998



MB M R

www.molnlycke.at

MoNo chem-pharm Produkte GmbHLeystrasse 129

1200 Vienna

Tel.: +43-1-33006-71-0

Fax: +43-1-3300671-38

Contact: Dr. Dipl.-Ing. Bernhard Wittmann

Founded: 2000


Sector of activities: R&D, production, services, sales [email protected]

MTG Medizinisch technische Geräte Erzeugungs- und Vertriebsgesellschaft mbHRömergasse 271160 ViennaTel.: +43-1-59791-52Contact: Roswitha PlatnerSector of activities: sales

[email protected]

Müller Medizinische Labormesstechnik Ges.m.b.H.Güpferlingstrasse 11

1170 Vienna

Tel.: +43-1-48543-77

Fax: +43-1-48543-7725


[email protected]

B M R

B M R

B M R



MySugr Apps OGSiebenbrunnengasse 44

1050 Vienna

Tel.: +43-699-1360-9590

Contact: Frank Westermann

Founded: 2010

Staff: 5



M

B M R

Mycosafe Diagnostics GmbHVeterinärplatz 1

1210 Vienna

Tel.: +43-1-25077-2150

Fax: +43-1-25077-2190

Contact: Prof. Dr. Renate Rosengarten

Founded: 2003

Staff: 20



[email protected]

[email protected]://mysugr.com

NABRIVA Therapeutics AGLeberstrasse 20

1110 Vienna

Tel.: +43-1-74093-0

Fax: +43-1-74093-1900

Contact: Petra Taylor

Founded: 2006

Staff: 42



[email protected]

NBS-C BioScience & Consulting GmbH Leberstrasse 20

1110 Vienna

Tel.: +43-1-74895-00

Fax: +43-1-74895-01

Contact: Mag. Dr. Frank Kricek (CEO)

Founded: 2008

Staff: 3



B M R

B M R

B M R



Novartis Institutes for BioMedical Research GmbH & Co. KG Muthgasse 11/2

1190 Vienna

Tel.: +43-1-866-340

Fax: +43-1-866-34285

Contact: Prof. Dr. Anton Stütz

Founded: 1970



NNeurodata GmbHSchulzgasse 24

1230 Vienna

Tel.: +43-1-667-9977

Fax: +43-1-667-4499

Contact: Herbert Schachinger (Sales Manager)


[email protected]

New England Nuclear Corp. GmbHBiotechnologie/Radiopharmaka

Spandlgasse 58

1220 Vienna

Tel.: +43-1-2857-785

Fax: +43-1-2857-780

Contact: Karl Steinitz

Founded: 1972



Nova BiomedicalLaxenburger Strasse 33/6

1100 Vienna

Tel.: +43-1-60309-700

Fax: +43-1-60309-702

Contact: Manfred Ofner (Managing Director)

Founded: 1997


www.novartis.at

B M R

B M R

B M R

b M R



Novo Nordisk Pharma GmbH Opernring 3

1010 Vienna

Tel.: +43-1-405-1501

Fax: +43-1-408-3204

Contact: Dr. Joachim Buttgereit

Staff: 43


N

www.novonordisk.at

NP Neumann & Partners GmbHSchwarzenbergplatz 3

1010 Vienna

Tel.: +43-1-205588-31

Fax: +43-1-205588-22

Contact: Elisaweta Bubits


[email protected]

NUTRICIA GmbHJochen-Rindt-Strasse 37

1230 Vienna

Tel.: +43-1-68826-260

Fax: +43-1-68826-26666

Contact: Steffen Dreher


[email protected]

Nycomed Pharma GmbHEURO PLAZA, Gebäude F, Technologiestrasse 5

1120 Vienna

Tel.: +43-1-8150-202

Fax: +43-1-8150202-900

www.nycomed.at

b M R

B M R

B M R

B M R



Octapharma Pharmazeutika Produktionsgesellschaft mbH Oberlaaer Strasse 235

1100 Vienna

Tel.: +43-1-61032-1313

Fax: +43-1-6103-2300

Contact: Herr Wicsizec

Founded: 1983



O

www.octapharma.com

Odelga Handelsgesellschaft mbHAnschützgasse 1

1150 Vienna

Tel.: +431-1-89147

Fax: +43-1-89147-213

Contact: Herbert Kacher


[email protected]

Österreichische Forschungsförderungsgesellschaft mbH (FFG)Sensengasse 1

1090 Vienna

Tel.: +43-5-7755-0

Fax: +43-5-7755-97900

Contact: Dr. Birgit Mayer

Founded: 2004


Österreichische Gesellschaft für Molekulare Biowissenschaften und Biotechnologie - ÖGMBTMuthgasse 18

1190 Vienna

Tel.: +43-1-47654-6394

Fax: +43-1-36006-6392

Contact: Andrea Veitschegger (Managing Director)

Founded: [email protected]

b M R

B M R

B M R

B M R



OOLERUP GmbHLöwengasse 47/6

1030 Vienna

Tel.: +43-1-7101500-00

Fax: +43-1-7101500-10

Contact: Dr. Roswitha Keller

Founded: 1998


Olympus Austria GmbHShuttleworthstrasse 25 | 1210 Vienna

Tel.: +43-1-29101-0

Fax: +43-1-29101-222

Contact: Norbert Vrany (Quality Management)


Working fields: electromechanical medical technology, non-active implantable

technology, ophthalmic and optical technology, reusable instruments, single

use technology


OmniChrom Handels-GmbHFrömmlgasse 40-42/15

1210 Vienna

Tel.: +43-1-278-5701

Working fields: human health, agricultural biotechnology, industrial processing,

lab equipment, consumables/reagents


www.omnichrom.com

onepharmVeterinärplatz 1

1210 Vienna

Tel.: +43-1-25077-5900

Fax: +43-1-25077-5999

Contact: Bernhard Küenburg (CEO)




Sector of activities: production, services

[email protected]

B M R

B M R

B M R

B M R



Oonepharm Beteiligungs GmbHBillrothstrasse 39/3/101190 ViennaFounded: 2005

OPTOTEAM Präzisionsinstrumente Vertriebsgesellschaft m.b.H.Mosetiggasse 3

1230 Vienna

Tel.: +43-1-48449-000

Contact: Erwin Brenner

Founded: 1990

Staff: 6



OrthoMed GanganalyseKahlenberger Strasse 1E/9

1190 Vienna

Tel.: +43-688-819-3513

Contact: Sandrina Illes (MSc)

Founded: 2010

Staff: 1

Working fields: electromechanical medical technology


ORTHOMED Medizintechnik GmbHAnnagasse 5/1/Top 4

1010 Vienna

Tel.: +43-1-53208-31

Fax: +43-1-53208-3431

Contact: Eva Stricker

[email protected]

B M R

B M R

B M R

B M R



OOrthorobot Medizintechnik GmbHWaidhausenstrasse 11

1140 Vienna

Tel.: +43-1-91136-38

Fax: +43-1-91136-389

Contact: Erich Silli (CEO)

Founded: 1999

Staff: 4

Working fields: dental technology


[email protected]

Otto Bock Healthcare Products GmbHKaiserstrasse 39

1070 Vienna

Tel.: +43-1-523-37860

Fax: +43-1-523-2264

Contact: Dr. Hans Dietl (Managing Director)


Working fields: active implantable technology, technical aids for disabled,

software for medicine, telemedicine and eHealth


PAMO Medizintechnik GmbHAmeisgasse 57

1140 Vienna

Tel.: +43-416-5550

Fax: +43-416-5551

Founded: 2010


[email protected]

Paradigm Spine Austria GmbHFischhof 3/6

1010 Vienna

Tel.: +43-1-74040-5713

Fax: +43-1-74040-5714


[email protected]

B M R

B M R

B M R

B M R



PPBD DiagnosticsHofmühlgasse 13/2/6

1060 Vienna

Tel.: +43-664-3567-099

Fax: +43-1-597-0338

Contact: Paul Botan


[email protected]

PDC Biotech GmbHKärntner Ring 10, 5th Floor, Top 12

1010 Vienna

Tel.: +43-1-89000-77

Contact: Diane Kalina (Managing Director, EVP)

Founded: 2008

Staff: 4


Sector of activities: R&D, productionwww.pdcbiotech.com

PerkinElmer VertriebsgmbHBrunner Strasse 59, Bau 42

1230 Vienna

Tel.: +43-1-60731-57

Contact: Martin Greber


[email protected]

Phadia Multiplexing Diagnostics GmbH Donau-City-Strasse 1

1220 Vienna

Tel.: +43-1-2699-505

Contact: Alexandra Sauer

Founded: 1999



www.phadia.com

B M R

B M R

B M R

b M R



PPharm-Allergan GmbHWienerbergstrasse 11Twin Tower 12 A1100 ViennaContact: Dr. Thomas KellerFounded: 2006Working fields: human healthSector of activities: sales

[email protected]

Pharmig – Verband der pharmazeutischen Industrie ÖsterreichsGarnisongasse 4/1/6

1090 Vienna

Tel.: +43-40-602900

Fax: +43-40-602909

Contact: Dr. Jan Oliver Huber (General Secretary)

[email protected]

Philips Austria GmbH HealthcareTriester Strasse 64 | 1100 Vienna

Tel.: +43-1-60101-1392 | Fax: +43-1-60101-1319

Contact: J. Robert Pfarrwaller, Robert Körbler

Founded: 1926

Working fields: hospital hardware, single use technology, diagnostic and

therapeutic radiation technology, software for medicine, telemedicine and

eHealth, others


[email protected]/healthcare

Photo Dynamic Therapy LLCAnnagasse 11010 ViennaTel.: +43-1-369-7030Fax: +43-1-369-7031Contact: Günther HofmannFounded: 1994Working fields: human healthSector of activities: services, sales [email protected]

www.pdt.at

B M R

B M R

B M R

B M R



Pohlig & Tappe GmbH & Co KGAltmannsdorfer Strasse 89

1120 Vienna

Tel.: +43-1-8040-800-11

Contact: Kurt Pohlig

PPhotonic Optische Geräte GmbH & Co. KGSeeböckgasse 59

1160 Vienna

Tel.: +43-1-4865-691-0

Fax: +43-1-4865-691-33

Founded: 1986

Working fields: electromechanical medical technology, ophthalmic and optical

technology, reusable instruments


PKP Handelsges.m.b.H.Schopenhauerstrasse 51

1180 Vienna

Tel.: +43-1-40578-46

Fax: +43-1-40578-4640

Contact: Ing. Norbert Jirak


[email protected]

planer dentaprise GmbHKranzgasse 22

1150 Vienna

Tel.: +43-1-4068-134

Fax: +43-1-4082-219

Contact: Konrad Frey

[email protected]

[email protected]

B M R

B M R

B M R

B M R



PPONTIS Capital GmbHLöwelstrasse 12

1010 Vienna

Tel.: +43-5333-2330

Fax: +43-5333-23330

Contact: Mag. Gerhard Fiala

[email protected]

PortConsult GmbHObere Donaustrasse 65-2-8

1020 Vienna

Tel.: +43-1-890-3951

[email protected]

PP Capital AGKürschnergasse 4

1210 Vienna

Tel.: +43-1-25099-130

Fax: +43-1-25099-135

Contact: Dr. Florian Kreuzbauer

Founded: 2007

[email protected]

PR&D – Kommunikationsdienstleistung GmbHMariannengasse 8

1090 Vienna

Tel.: +43-1-505-7044

Fax: +43-1-505-5083

Contact: Dr. Till Jelitto

Founded: 2001

Staff: 3


Public Relations für Wissenschaft & Bildung

B M R

B M R

B M R

B M R



RQiagen VertriebsGmbHLöwengasse 47/ Top 6

1030 Vienna

Fax: +43-80028-1019

Founded: 1998

[email protected]

quantensprung consulting GmbHWipplingerstrasse 12/10

1010 Vienna

Tel.: +43-1-9232-3850

Fax: +43-1-9232-38585

[email protected]

Quintiles GmbHStella-Klein-Löw-Weg 15, Rund 4, Haus B, OG4

1020 Vienna

Tel.: +43-1-726-3010-0

Fax: +43-1-726-3010-1100

Contact: Jan Filakovszky (Managing Director)

Founded: 1996


Redl Life Science Patent AttorneysDonau-City-Strasse 1

1220 Vienna

Tel.: +43-1-20501-47100

Fax: +43-1-20501

Contact: Dr. Gerda Redl

Founded: 2008

[email protected]

B M R

B M R

B M R

B M R



RF. Reiner & Co. GesmbHPelikangasse 6

1090 Vienna

Tel.: +43-1-4055287

Fax: +43-1-4081450

Contact: Heinz Tinkel


[email protected]

RELUX Lichtmedizintechnik GmbHWienerbergstrasse 7

1100 Vienna

Tel.: +43-1-31907-99

Fax: +43-1-31907-9915

Contact: Brigitte Rumpold

Founded: 2006

Staff: 6

Working fields: electromechanical medical technology


Remesco HandelsgesmbHGrinzinger Allee 5/25

1190 Vienna

Tel.: +43-1-32850-88

Fax: +43-1-32829-49

Contact: Franz Reisinger (Managing Director)

Founded: 1997

Staff: 8



[email protected]

REMESCO

REMONDIS Austria GmbHVohburggasse 4

1210 Vienna

Tel.: +43-1-3303-900

Contact: Thomas Breitkopf

[email protected]

B M R

B M R

B M R

B M R



RRichard Bittner AGReisnerstrasse 55-57

1030 Vienna

Tel.: +43-1-5030-972-0

Fax: +43-1-5030-972-40

Contact: Marc Coucke (CEO)

Founded: 1977

[email protected]

Richard Wolf Austria GmbHWilhelminenstrasse 93a

1160 Vienna

Tel.: +43-1-4055-151

Fax: +43-1-4055-45445

Founded: 1994

Staff: 11

Working fields: hospital hardware, reusable instruments, single use

technology, software for medicine, telemedicine and eHealth

Sector of activities: [email protected]://at.richard-wolf.com

Roche Diagnostics GmbHEngelhorngasse 31210 ViennaTel.: +43-1-27787-0Fax: +43-1-27787-12Contact: Mag. (FH) Christine Stadler-HäbichFounded: 1999Working fields: human healthSector of activities: sales [email protected]

www.roche.at

Rösch & HandelScheringgasse 2

1140 Vienna

Tel.: +43-1-60414-900

Fax: +43-1-60414-906

Contact: Mag. Klaus Stromberger

Founded: 1890


B M R

B M R

B M R

B M R



RRoraco Ges.m.b.H.Markhofgasse 19

1030 Vienna

Tel.: +43-1-310-5868

Fax: +43-1-310-3955

Contact: Werner Rabsch

Founded: 1947

Staff: 16

Sector of activities: production, sales [email protected]

Rüsch Austria Gesellschaft mbHLazarettgasse 24

1090 Vienna

Tel.: +43-1-402-4772

Fax: +43-1-402-477277

Contact: Katrin Lhotka

Working fields: anesthetic and respiratory technology, reusable instruments,



RWM Medizintechnik GmbHJochen-Rindt-Strasse 21

1230 Vienna

Tel.: +43-1-66200-61

Fax: +43-1-662 00 61

Contact: Robert Woisetschläger


[email protected]

S-TARget therapeuticsGastgebgasse 5-131230 ViennaTel.: +43-664-51600-32Contact: Christof Langer (CEO)Founded: 2010Staff: 4Working fields: human healthSector of activities: R&D [email protected]

www.s-target.com

B M R

B M R

B M R

B M R



Sanochemia Pharmazeutika AG Boltzmanngasse 11

1010 Vienna

Tel.: +43-1-3191-456-335

Fax: +43-1-3191-456-344

Contact: Margarita Hoch

Founded: 1980

Staff: 200



Savira Pharmaceuticals GmbHVeterinärplatz 1, Building IA

1210 Vienna

Tel.: +43-1-25077-5904

Fax: +43-1-25077-5999

Contact: Oliver Szolar (CEO)

Founded: 2009

Staff: 9


SS.MED Handels GmbHZachgasse 1

1220 Vienna

Tel.: +43-1-513-9152

Fax: +43-1-513-8695

Contact: Ing. Max Weese (Managing Director)

Founded: 1997

Staff: 5



[email protected]

[email protected]

Sanofi-aventisLeonard-Bernstein-Strasse 10

1220 Vienna

Tel.: +43-1-80185-0

Fax: +43-1-80185-8000


www.sanofi-aventis.at

[email protected]

R

B M R

b M

B M R

B M R



SDr. A. & L. Schmidgall GmbH & Co KGWolfganggasse 45-47

1121 Vienna

Tel.: +43-1-81158-0

Founded: 1962

Staff: 49



F. Schmidl & Co GmbHMariahilfer Gürtel 16

1060 Vienna

Tel.: +43-1-5968-5200

Fax: +43-1-5968-521

Contact: Alfred Mayr

Staff: 22

[email protected]

Schober Laborgeräte & Umweltanalytik KEGBillrothstrasse 6

1190 Vienna

Tel.: +43-1-699-882

Founded: 1981

[email protected]

Dr. Schuhfried Medizintechnik GmbHVan-Swieten-Gasse 10

1090 Vienna

Tel.: +43-1-4054-206

Fax: +43-1-4054-464

Contact: Gernot Schuhfried

Founded: 1949


B M R

B M R

B M R

B M R



Sempermed Semperit Technische Produkte GmbHModecenterstrasse 22

1030 Vienna

Tel.: +43-1-79777-520

Fax: +43-1-79777-630

Contact: Clemens Bichler




SSchülke & Mayr Ges.m.b.HSeidengasse 9, Top 21 | 1070 ViennaTel.: +43-1-5232-501-0Fax: +43-1-5232-501-60Contact: Mag. Alexis DujmicFounded: 1988Staff: 27Working fields: consumables/reagents, othersSector of activities: production, services, sales [email protected]

www.schuelke.com

science2public e.U.Stiftgasse 21/16

1070 Vienna

Tel.: +43-1-89042-8312

Fax: +43-1-89042-8310

[email protected]

Semadeni (Europe) AGKürschnergasse 6

1210 Vienna

Tel.: +43-1-25655-00

Fax: +43-1-25655-004

Contact: Roland Pernsteiner

Founded: 1952


Sector of activities: production, sales [email protected]

[email protected]

B m R

B M R

B M R

B M R



Ssense product GmbHLandstrasser Hauptstrasse 34/3/8

1030 Vienna

Tel.: +43-1-71869-60

Fax: +43-1-71517-24

Contact: Thomas Kogler

[email protected]

SER Solutions Österreich GmbHFloridsdorfer Hauptstrasse 1

1210 Vienna

Tel.: +43-1-50395-55

Contact: Hartmut Gailer

Founded: 1984

Staff: 34


Sector of activities: R&D, services, sales

www.ser.at

Serobac Labordiagnostika Handelsgesellschaft mbHUntere Viaduktgasse 25

1030 Vienna

Tel.: +43-1-71372-92

Fax: +43-1-71237-99

Contact: Mag. Barbara Schorr

Working fields: consumables/[email protected]

Siemens AG ÖsterreichSiemensstrasse 92

1210 Vienna

Contact: Mag. Brigitte Ederer

Founded: 1939


[email protected]

B M R

B M R

B M R

B M R



SSIGMA-ALDRICH Handels GmbHWienerbergstrasse 41

1120 Vienna

Tel.: +43-1-6058-190

Fax: +43-1-6058-120

Contact: Thomas Prulamp

Founded: 1993


Sector of activities: services, saleswww2.sigma-aldrich.com

Sigmapharm Arzneimittel GmbHLeystrasse 129

1200 Vienna

Tel.: +43-1-3300671-0

Fax: +43-1-3300671-38

Contact: Kurt Schaffer

Founded: 1973



Signalomics™ GmbHLeberstrasse 18

1110 Vienna

Tel.: +43-1-236-2185-204

Fax: +43-1-236-2185-299

Contact: Mag. (FH) Robert Kuntner (MBA (Director Finance))

Founded: 2006

Staff: 12



SIGNATIS Pharma GmbHHietzinger Hauptstrasse 80

1130 Vienna

Tel.: +43-1-87916-760

Contact: Wolfgang Krickl


[email protected]

B M R

B M R

B M R

B M R



S

[email protected]

Sigvaris – medizinische Kompressionsstrümpfe Gesellschaft mbHHietzinger Hauptstrasse 22/A/2/51130 ViennaTel.: +43-1-8776-912Fax: +43-1-8776-915Contact: Alfred KornerSector of activities: sales

[email protected]

Sinapharm GmbH Dresdner Strasse 62-64/2/12

1200 Vienna

Tel.: +43-1-408610-600

Fax: +43-1-408610-620

Founded: 2005

Staff: 6


Softwaremanufaktur Grünberg & Redl OGGierstergasse 6

1120 Vienna

Tel.: +43-181-10616

Fax: +43-181-10618

Contact: Andreas Redl


Working fields: human health, non-specific services,

bioinformatics

Sector of activities: servicesar@die-softwaremanufaktur.comwww.die-softwaremanufaktur.com

Solvay Österreich GmbHStättermayergasse 28-30

1150 Vienna

Tel.: +43-1-716880

Fax: +43-1-710426

Contact: Mag. Helmut Leeb

Founded: 1883

Staff: 55

www.solvay.at

B M R

B M R

B M R

B M R



SSonn & Partner PatentanwälteRiemergasse 14

1010 Vienna

Tel.: +43-1-5128405

Fax: +43-1-5129805

Founded: 1851


[email protected]

sonoArena Vertriebs GmbHJochen-Rindt-Strasse 21 | 1230 Vienna

Tel.: +43-1-89041-83

Fax: +43-1-89041-8322

Contact: Bernhard Kowanz (Managing Director)


Working fields: electromechanical medical technology, single use technology,

diagnostic and therapeutic radiation technology, technical aids for disabled,

software for medicine, telemedicine and eHealth

Sector of activities: production, services, [email protected]

Sorbus GmbHGraumanngasse 7

1150 Vienna

Contact: Dr. Frank Sams-Dodd

Founded: 2010

Staff: 3

[email protected]://sorbus.at

SPANTEC GmbHGumpendorfer Strasse 132/2/5

1060 Vienna

Tel.: +43-1-58513-592

Fax: +43-1-58513-591

Contact: DI (FH) Armin Blaha (Managing Director)

Founded: 2008

Staff: 10


Sector of activities: production www.spantec.at

B M R

B M R

B M R

B M R



SSpine-Med Ges.m.b.H.Twarochgasse 11

1170 Vienna

Tel.: +43-1-4799-281

Fax: +43-1-4700-395

Contact: Rudolf Bernegger


Working fields: non-active implantable technology, reusable instruments,

single use technology


[email protected] www.spinemed.at

St. Jude Medical Medizintechnik GmbHWienerbergstrasse 7

1100 Vienna

Tel.: +43-1-607-3060

Contact: Jürgen Bernhard


[email protected]

STADA Arzneimittel GmbHMuthgasse 36

1190 Vienna

Tel.: +43-1-36785-850

Fax: +43-1-36785-8585

Contact: Bernd Leiter


[email protected]

Stryker GmbHAm Euro Platz 2 | 1120 Vienna

Tel.: +43-1-813-2000

Fax: +43-1-813-1616

Contact: Eric R. Perucco



nonactice implantable technology, reusable instruments, single use technology,

components based on biological materials


B M R

B M R

B M R

B M R



SStudyMaker – Clinical Trial Management e.U.Wallrisstrasse 47/5

1180 Vienna

Tel.: +43-650-26666-64

Contact: Dr. Daniel Doberer (Managing Director)


[email protected]

Sumetzberger (Ing. Sumetzberger GmbH)Leberstrasse 108

1110 Vienna

Tel.: +43-1-74035

Fax: +43-1-74035-200

Founded: 1994

[email protected]

Sunmed Medizintechnische Produkte GmbHJochen-Rindt-Strasse 25

1230 Vienna

Tel.: +43-1-69922-99

Fax: +43-1-69922-991

Contact: Anton Mayrhauser (Managing Director)


Working fields: electromechanical medical technology, single use technology,

technical aids for disabled


[email protected]

SYMFONY ConsultingHugo-Meisl-Weg 11

1100 Vienna

Tel.: +43-680-3200-105

Contact: Sabine M. Fischer


www.symfony.at

B M R

B M R

B M R

B M R



SSZABO-SCANDIC HandelsgmbH & Co. KGQuellenstrasse 110

1100 Vienna

Tel.: +43-1-4893-9610

Fax: +43-1-4893-9617

Founded: 1963

Staff: 20



Technoclone GmbHBrunner Strasse 67

1230 Vienna

Tel.: +43-1-86373-0

Fax: +43-1-86373-44

Founded: 1987

Staff: 42


Sector of activities: R&D, production, services [email protected]

TeleCare Systems & Communication GmbHLinke Wienzeile 234

1150 Vienna

Tel.: +43-1-89988-0

Contact: Günter Melbinger

[email protected]

Telozo GmbHOffice Park I Top 4

1300 Vienna-Airport

Tel.: +43-1-7007-32551

Fax: +43-1-7007-32559

Contact: Prof. Joachim Schlund (R&D)





[email protected]

B M R

B M R

B m R

B M R



TThe Siesta Group GmbHSchlosshofer Strasse 11

1210 Vienna

Tel.: +43-1-95512-13

Fax: +43-1-95512-1350

Contact: Dr. Georg Dorffner (CEO)

Founded: 2001


Themis Bioscience GmbHMuthgasse 11/2

1190 Vienna

Tel.: +43-1-236-7151

Fax: +43-1-236-7151-74

Contact: Dr. Erich Tauber (CEO)

Founded: 2009

Staff: 5



Thermo Fisher Scientific wissenschaftliche Geräte GmbHWehlistrasse 27b

1200 Vienna

Tel.: +43-1-33350-34

Fax: +43-1-33350-3426

Contact: Horst Maglia

Founded: 1976


Tiani Spirit GmbHGuglgasse 6

Gasometer A

1110 Vienna

Tel.: +43-1-23511-8511

Contact: Martin Tiani (Managing Director)

[email protected]

B M R

B M R

B M R

B M R



TTissueGnostics GmbHTaborstrasse 10/2/8

1020 Vienna

Tel.: +43-1-21611-90

Fax: +43-1-21611-9090

Contact: Katja Österreicher (Executive Vice President)

Founded: 2003

Staff: 35



[email protected]

Torrex Chiesi Pharma GmbH Gonzagagasse 16/161010 ViennaTel.: +43-1-4073-919-0Fax: +43-1-4073-919-99999Contact: Dr. Wolfgang HarrerFounded: 1995Working fields: human healthSector of activities: R&D, production, services [email protected]

www.torrex-chiesi.com

Tube Pharmaceuticals GmbHLeberstrasse 20

1110 Vienna

Tel.: +43-1-740935-100

Contact: Dr. Wolfgang Richter

Founded: 2011



www.tubepharma.at

TÜV Austria Services Department Medical Devices Deutschstrasse 10

1230 Vienna

Tel.: +43-1-610 91-6502

Fax: +43-1-610 91-6505

Founded: 1872

Working fields: others

Sector of activities: services [email protected]/medizin

B M R

b M R

B M R

B M R



VTWO PI Signal Processing Applications GmbHSchönbrunner Strasse 131/5

1050 Vienna

Tel.: +43-1-523-8180

Fax: +43-1-524-5414

Contact: Dr. Ernestine Bennersdorfer (Business Development/Sales)

Founded: 2003

Staff: 8



[email protected]

Uniplan Medizintechnik GmbHArnikaweg 18

1220 Vienna

Tel.: +43-1-7343602-0

Contact: Alexander Koubele

[email protected]

Unitek Maschinenbau und -handels GmbHBlindengasse 3a

1080 Vienna

Tel.: +43-1-32255-100

Fax: +43-1-33255-15

Contact: DI Bernd Klein


[email protected]

VAMED Standortentwicklung und Engineering GmbH & Co.KGSterngasse 5

1232 Vienna

Tel.: +43-1-60127-370

Fax: +43-1-60127-394

Contact: Ing. Gerhard Arthold

Working fields: human health, lab [email protected]

B M R

B M R

B M R

B M R



VVASEMA GmbH Brunner Strasse 67, Objekt 4, 1. Stock

1230 Vienna

Tel.: +43-676-43079-13

Contact: Dipl. Ing. Peter Hagl (CEO)

Founded: 2010

Staff: 3

Working fields: electromechanical medical technology, single use technology


VBC-Biotech Service GmbHBrehmstrasse 14 A

1110 Vienna

Tel.: +43-1-79665-7260

Fax: +43-1-79665-7221

Contact: Barbara Moesl

Founded: 2000

Staff: 7



Vela pharm. Entwicklung u. Laboranalytik GmbHBrunner Strasse 69/3 | 1230 Vienna

Tel.: +43-1-89059-7911

Fax: +43-1-89059-7910

Contact: Andreas Nechansky (COO), Armin Franz (CFO),

Dr. Markus Fido (CEO)




Verein Österreichischer Lebensmittel- und Biotechnologenc/o Universität für Bodenkultur

Muthgasse 18

1190 Vienna

Contact: Prof. Dr. Dipl.-Ing. W. Kneifel (President)

Founded: 1968

[email protected]/voelb

B M R

B M R

B M R

B M R



VVetWIDI Forschungsholding GmbHVeterinärplatz 1

1210 Vienna

Tel.: +43-1-25077-1047

Fax: +43-1-25077-1090

Contact: Mag. Christine Ruckenbauer

Founded: 2004

Staff: 2


Sector of activities: services www.vetwidi.at

Vidavis GmbHRooseveltplatz 4-5

1090 Vienna

Tel.: +43-664-130-1774

Fax: +43-1-3679-165-33

Contact: Dr. Johann Graus (Managing Director)


www.vidavis.com

Vienna Open LabDr. Bohr-Gasse 3

1030 Vienna

Tel.: +43-1-79044-4591

Fax: +43-1-79044-110

Contact: DI Maria Halaschek-Wiener

Founded: 2006

Staff: 4


ViennaLab Diagnostics GmbHGaudenzdorfer Gürtel 43-45

1120 Vienna

Tel.: +43-1-8120-156-0

Fax: +43-1-8120-156-19

Contact: Dr. Christian Oberkanins

Founded: 1990

Staff: 20



[email protected]

B M R

B M R

B M R

B M R



VViruSure GmbHTechGate Vienna

Wissenschafts- und Technologiepark

Donau-City-Strasse 1-8 | 1220 Vienna

Tel.: +43-1-2699-120

Fax: +43-1-2699-12022

Contact: Dr. Andrew Bailey (CEO)




[email protected]

VISTA MEDICAL Medizintechnik GmbHLinzer Strasse 76

1140 Vienna

Tel.: +43-1-786-2222


www.vistamedical.at

VIVISOL Heimbehandlungsgeräte GmbHRichard-Strauss-Strasse 10

1230 Vienna

Tel.: +43-1-524-6283

Fax: +43-1-524-1642

Contact: Mag. Andreas Budz

Founded: 1993

[email protected]

Vogelbusch Biocommodities GmbHBlechturmgasse 11

1051 Vienna

Tel.: +43-1-54661-0

Fax: +43-1-54529-79

Contact: Katharina Harlander (Marketing)

Founded: 2009

Staff: 38



[email protected] biocommodities.com

B M R

B M R

B M R

B M R



WVOMI – Vienna Open Medical InstitutePalais Todesco

Kärntner Strasse 51/ II/ Top 4

1010 Vienna

Tel.: +43-1-53386-58

Fax: +43-1-53386-5810

[email protected]

VWR International GmbHGraumanngasse 7 16/18

1150 Vienna

Tel.: +43-1-97002-0

Fax: +43-1-97002-600

Contact: Mag. Robert Schöls

Founded: 2002

Staff: 77


Sector of activities: [email protected]://at.vwr.com

Wagner & Munz GmbH AustriaMariahilferstrasse 123/3

1060 Vienna

Tel.: +43-1-5999-9480

Fax: +43-1-5999-9489

[email protected]

WAT Medizintechnik HandelsgmbHSchimmelgasse 18

1030 Vienna

Tel.: +43-1-713-6001

Fax: +43-1-713-600120

Founded: 1995

Staff: 4

Working fields: electromechanical medical technology, reusable instruments,

single use technology, technical aids for disabled


B M R

B M R

B M R

B M R



WWaters Ges.m.b.H.Hietzinger Hauptstrasse 145

1130 Vienna

Tel.: +43-1-877-1807

Fax: +43-1-877-1808



[email protected]

WEBA Sport- und Med. Artikel GmbHLieseneckgasse 6/2

1210 Vienna

Tel.: +43-1-2723550

Fax: +43-1-2723550-4


[email protected]

Werfen Austria GmbH Tillmanngasse 5

1220 Vienna

Tel.: +43-1-25046-0

Fax: +43-1-25046-100


[email protected]

Wiener Wissenschafts-, Forschungs- und Technologiefonds Schlickgasse 3/12

1090 Vienna

Tel.: +43-1-40231-4310

Fax: +43-1-40231-4320


www.wwtf.at

B M R

B M R

B M R

B M R



ZWilheim Müller RechtsanwälteRockhgasse 6

1010 Vienna

Tel.: +43-1-535-8008

Fax: +43-1-535-800850


[email protected]

Wirtschaftsagentur WienEbendorferstrasse 2

1010 Vienna

Tel.: +43-1-40000-8670

Fax: +43-1-4000-86584


[email protected]

Xenogenetic Biotechnologie GmbHSimmeringer Hauptstrasse 24

1110 Vienna

Tel.: +43-1-74040-414

Fax: +43-1-74040-415

Contact: Mag. Tanja Walzer (Project Manager),

Prof. Dr. Gottfried Brem (Managing Director)

Founded: 1997

Staff: 3

Working fields: non-specific [email protected]

Ze.Wa. medicalsystems GmbHAltmannsdorfer Strasse 104 | 1120 Vienna

Tel.: +43-1-58678- 00

Contact: Dr. Hubert Dreßler, Maria Simic (Office Manager),

Peter Buchner (MBA)



medical technology, in-vitro diagnostic technology, reusable instruments,

single use technology, technical aids for disabled


[email protected]

B M R

B M R

B M R

B M R



ZZimmer Austria GmbHGroßmarktstrasse 7a

1230 Vienna

Tel.: +43-1-61520-600

Fax: +43-1-61520-62

Contact: Werner Klika (Managing Director)

Founded: 1975

Staff: 31

Working fields: non-active implantable technology, reusable instruments


ZIT – Die Technologieagentur der Stadt Wien GmbHEbendorferstrasse 4

1010 Vienna

Tel.: +43-1-4000-86165

Fax: +43-1-4000-86587

Contact: Peter Halwachs


[email protected]

Zoll Medical Österreich GmbHWienerbergstrasse 11

1100 Vienna

Founded: 2004

Staff: 3




[email protected]

Zühlke Engineering (Austria) GmbHLandstrasser Hauptstrasse 71/2

1030 Vienna

Tel.: +43-1-71728-420

Fax: +43-1-71728-110

Founded: 2009



Sector of activities: R&D, services [email protected]

B M R

B M R

B M R

B M R



ZZYMED GmbHRennbahnweg 80

1220 Vienna

Tel.: +43-1-203-2566

Fax: +43-1-203-369520

Contact: Mag. Richard Weidinger (Managing Director)

Founded: 1979


Zytoprotec GmbHStadiongasse 2/13

1010 Vienna

Tel.: +43-1-406-2002

Fax: +43-1-406-2002-20

Contact: Prof. Dr. Christoph Aufricht (CSO)

Founded: 2007

Staff: 12



B M R

B M R

151DeFinitions

Glossary

Biotechnology is …

… defined as the application of science and technology to living organisms, as well as parts, products and models thereof, to alter living or non-living ma-terials for the production of knowledge, goods and services. the concept ap-plied to this survey was developed by the oeCD in 2004 (see P. 153).

A dedicated biotech company is …

… defined as a biotechnology active firm whose predominant activity involves the application of biotechnological tech-niques to produce goods or services and/or the performance of biotechno-logical r&D.

A biotech-active company is …

… defined as a firm that applies biotech-nological techniques for the purpose of implementing new or significantly im-proved products or processes (per the oslo manual (oeCD, 1997) for the mea-surement of innovation). it excludes end users which innovate simply by using bio-technological products as intermediate inputs (for instance, detergent manufac-turers which change their formulation to include enzymes produced by other firms via biotechnology techniques).

A medical device is …

… defined as any instrument, apparatus, appliance, software, material or other ar-ticle, whether used alone or in combina-tion, including the software intended by its manufacturer to be used specifically for diagnostic and/or therapeutic pur-poses such as: diagnosis, prevention, monitoring, treatment or alleviation of a disease, injury, handicap or the investi-gation, replacement or modification of the anatomy or of a physiological pro-cess.

A dedicated medtech company is …

… defined as a company whose key aims are the manufacture of medical de-vices or the provision of services from the field of medical technology.

A medtech-active company is …

… defined as a company with a main corporate aim that is not exclusively the manufacture of products or the provision of services within medical technology.

A life science related company is …

... defined as a company providing technical products and/or biotechnol-ogy/medical device-specific services for dedicated and active companies. examples are commercial research in-stitutions, sales offices, suppliers, con-sultants, information providers and pub-lishers, fairs, recruiters and other.

153metHoDoLoGy

methodology of this report

Biotechnology: In December 2004, the OECD standardized the broad range of existing definitions of the term biotechnology. Since then, all OECD countries have been called upon to carry out surveys on biotechnology, following the so-called Framework for Biotechnology Statistics (www.oecd.org). The OECD recognizes two dif-ferent categories of companies within the biotech industry: dedicated bio-technology company and other bio-technologically active companies. The first of these definitions, according to the OECD, applies to biotechnologi-cally active enterprises, whose core company goals are the application of biotechnological procedures in the manufacturing of products, the sup-ply of services or in the execution of biotechnological research and devel-opment.

Unlike the dedicated biotech com-panies, the central aims of other bio-technologically active companies do not exclusively lie in the application of biotechnological procedures. The OECD thereby also includes in this category companies where biotech-nology makes up only one part of the business activity. Companies are defined as biotechnologically active companies if they use biotechnological procedures for recently developed or significantly improved products or pro-duction processes. The central com-pany aims must not be solely in the use of biotechnological procedures for the production of products, the sup-ply of services or in the execution of biotechnological research and devel-opment. Examples of such companies are pharma firms, chemical companies or seed manufacturers.

Medtech: There are two challenges when attempting to isolate medical technology conceptually. On one hand, the field is extremely diverse in terms of content and the range of products

covers everything from latex gloves to CAT scanners. On the other hand, due to the high innovation rate, new and above all innovative products are con-tinually being added.

At licensing level, the term ‘medical device’ applies as specified in EU di-rective 93/42/EEC. The directive differ-entiates between medical devices, ac-cessories, in-vitro diagnostic medical devices and custom-made devices.

The medical device nomenclature “GMDN” (global medical device no-menclature for the purpose of regula-tory data exchange) was additionally introduced in November 2001 to better illustrate the different facets of medical technology in international compari-son. The GMDN consolidates the wide variety of medical technolo gy products into generic categories. It replaced the previously applicable universal medi-cal device nomenclature system (UM-DNS) which was no longer up-to-date. GMDN is adjusted on an ongoing basis and currently contains 14 main catego-ries with almost 9,000 terms and over 10,000 synonyms for medical devices. The nomenclature was adjusted for the survey. One category (supplementary equipment) was deleted an two new ones were added: “software, eHealth” and “others”. These categories form the basis for the survey described in this brochure.

It has been supplemented by the defi-nition of dedicated companies which was coined by the Organisation for Economic Cooperation and Develop-ment (OECD) and was developed for biotechnology in 2004. With this in mind, when applied to medical tech-nology, a company is described as a “dedicated company” if its key aims are the manufacture of products or the provision of services from the field of medical technology. A company is deemed to be a “company active in

medical technology” if its main corpo-rate aim is not exclusively the manu-facture of products or the provision of services within medical technology.

Survey: BIOCOM AG created a ques-tionnaire based on these definitions for the purposes of this survey. Between March and June 2011 BIOCOM con-tacted a total of 402 Austrian medtech companies and 214 biotech firms ask-ing them to fill in the questionnaire. The corporate database of BIOCOM AG was used in the selection of those written to and in addition the GMDN classification was used to identify other potential companies. In Vienna 20 medtech companies and 37 bio-tech firms responded, either in writing or by way of additional supplementary telephone interviews. This equates to a response rate of 52% in medtech and 61% in biotech.

In line with OECD guidelines, care was taken when selecting the companies to ensure that all the companies record-ed are involved in medical technology in Austria and are based in the country. For this reason, we also considered companies that are majority-owned by a non-Austrian parent company but which have R&D activities in Austria. The survey was only conducted for the Austrian sites of a company when recording jobs, business figures and business segments. A company with more than one site in Austria is only taken into consideration once with correspondingly accumulated values. The cut-off date for the survey was 31.12.2010.

ImprintThis report is based on data obtained through the evaluation of a written survey among Austria's life science companies carried out by BIOCOM AG, Berlin in close cooperation with austria wirt-schaftsservice and LISAvienna in spring 2011. For more information please refer to page 153. The editorial staff comprises Dr. Patrick Dieckhoff, Dr. Bernd Kaltwaßer (both BIOCOM) and DI (FH) Maria Hinnerth (LISAvienna). The data were collected by Simone Ding (BIOCOM). The layout was designed by Benjamin Röbig (BIOCOM) and CREVO. We thank all companies supporting this sur-vey! The layout, graphics and other contents of this brochure of the Viennese life science cluster are protected by copyright law.Berlin, November 8, 2011

Contact:LISAvienna, Ungargasse 37, A-1030 Vienna, www.LISAvienna.atBIOCOM AG, Lützowstrasse 33–36, D-10785 Berlin, www.biocom.de

Coverentwürfe2 copy.indd 1 07.11.11 17:06Coverentwürfe2 copy.indd 2 02.11.11 14:38Coverentwürfe2 copy.indd 2 02.11.11 14:38

Vie

nna

Life

Sci

ence

Rep

ort

Sec

tor

Sur

vey:

Fac

ts a

nd D

irect

ory

2011

/201

2

Date post:	01-Mar-2016
Category:	Documents
Upload:	lisavienna-connecting-life-sciences
View:	262 times
Download:	6 times

Life Science Report Vienna 2011

Documents